{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:36:19Z","timestamp":1793252179593,"version":"4.5.0"},"reference-count":382,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fang Qianxun-Tang Zeyuan Ophthalmic Clinical Medicine Charity Project","award":["0040206107039"],"award-info":[{"award-number":["0040206107039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Thyroid hormone (TH) signaling plays a pivotal role in maintaining metabolic homeostasis across multiple organ systems, including the eye. Proper ocular development depends on precise regulation of TH levels, as deviations from this dynamic range can result in ophthalmopathy. Emerging evidence underscores the involvement of TH signaling in various ocular pathologies, such as diabetic retinopathy. Notably, suppressing TH signaling has been shown to preserve cone photoreceptors in mouse models of retinal degeneration, highlighting the intricate interplay between TH signaling and photoreceptor viability. Additionally, the well-documented association between abnormal thyroid function and proptosis further emphasizes the critical role of TH signaling in orbital tissue homeostasis. The biological effects of TH are mediated through its binding to thyroid hormone receptors (TRs), which initiate downstream genomic and non-genomic pathways. Of particular interest is the role of deiodinases (DIOs), which modulate local TH signaling in a tissue- and temporally specific manner, independent of systemic TH levels. Despite the recognized importance of TH signaling in ophthalmopathy, significant gaps remain in our understanding of its cellular and molecular mechanisms. Future studies focusing on TH signaling within specific ocular cell lineages are essential for elucidating the underlying mechanisms and uncovering new therapeutic opportunities. This review aims to provide a comprehensive overview of TH signaling in ocular physiology and pathology, with an emphasis on advancing our understanding of its molecular mechanisms.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1186\/s40659-025-00618-1","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:17:27Z","timestamp":1751429847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Thyroid hormone signaling in ocular development and diseases"],"prefix":"10.1186","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1623-7964","authenticated-orcid":false,"given":"Pengbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Ji","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianfeng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"618_CR1","doi-asserted-by":"publisher","first-page":"e13260","DOI":"10.1111\/acel.13260","volume":"19","author":"BR Gauthier","year":"2020","unstructured":"Gauthier BR, Sola-Garc\u00eda A, C\u00e1liz-Molina M\u00c1, Lorenzo PI, Cobo-Vuilleumier N, Capilla-Gonz\u00e1lez V, Martin-Montalvo A. Thyroid hormones in diabetes, cancer, and aging. Aging Cell. 2020;19:e13260.","journal-title":"Aging Cell"},{"key":"618_CR2","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/hep.31296","volume":"72","author":"MJ Ritter","year":"2020","unstructured":"Ritter MJ, Amano I, Hollenberg AN. Thyroid Hormone Signaling and the Liver. Hepatology. 2020;72:742\u201352.","journal-title":"Hepatology"},{"key":"618_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","volume":"14","author":"A Jabbar","year":"2017","unstructured":"Jabbar A, Pingitore A, Pearce SHS, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14:39\u201355.","journal-title":"Nat Rev Cardiol"},{"key":"618_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/1871530319666190618120107","volume":"20","author":"MM El-Eshmawy","year":"2020","unstructured":"El-Eshmawy MM, Shahin M. Thyroid and Eye: Where They Meet in Clinical Practice. Endocr Metab Immune Disord Drug Targets. 2020;20:39\u201349.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"618_CR5","doi-asserted-by":"publisher","first-page":"eaau6348","DOI":"10.1126\/science.aau6348","volume":"362","author":"KC Eldred","year":"2018","unstructured":"Eldred KC, Hadyniak SE, Hussey KA, Brenerman B, Zhang P-W, Chamling X, Sluch VM, Welsbie DS, Hattar S, Taylor J, et al. Thyroid hormone signaling specifies cone subtypes in human retinal organoids. Science. 2018;362:eaau6348.","journal-title":"Science"},{"key":"618_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1053\/j.semperi.2008.09.009","volume":"32","author":"J Rovet","year":"2008","unstructured":"Rovet J, Simic N. The Role of Transient Hypothyroxinemia of Prematurity in Development of Visual Abilities. Sem Perinatol. 2008;32:431\u20137.","journal-title":"Sem Perinatol"},{"key":"618_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1089\/thy.2009.0128","volume":"20","author":"N Simic","year":"2010","unstructured":"Simic N, Westall C, Astzalos EV, Rovet J. Visual abilities at 6 months in preterm infants: impact of thyroid hormone deficiency and neonatal medical morbidity. Thyroid. 2010;20:309\u201315.","journal-title":"Thyroid"},{"key":"618_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s10792-018-0959-2","volume":"39","author":"SA Yassin","year":"2019","unstructured":"Yassin SA, Al-Dawood AJ, Al-Zamil WM, Al-Ghamdi MA, Al-Khudairy ZN. Comparative study of visual dysfunctions in 6\u201310-year-old very preterm- and full-term-born children. Int Ophthalmol. 2019;39:1437\u201343.","journal-title":"Int Ophthalmol"},{"key":"618_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/bjo.79.5.447","volume":"79","author":"HJ Dowdeswell","year":"1995","unstructured":"Dowdeswell HJ, Slater AM, Broomhall J, Tripp J. Visual deficits in children born at less than 32 weeks\u2019 gestation with and without major ocular pathology and cerebral damage. Br J Ophthalmol. 1995;79:447\u201352.","journal-title":"Br J Ophthalmol"},{"key":"618_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/procel\/pwad007","volume":"14","author":"M Wei","year":"2023","unstructured":"Wei M, Sun Y, Li S, Chen Y, Li L, Fang M, Shi R, Tong D, Chen J, Ma Y, et al. Single-cell profiling reveals M\u00fcller glia coordinate retinal intercellular communication during light\/dark adaptation via thyroid hormone signaling. Protein Cell. 2023;14:603\u201317.","journal-title":"Protein Cell"},{"key":"618_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.beem.2017.09.004","volume":"31","author":"F Roelfsema","year":"2017","unstructured":"Roelfsema F, Boelen A, Kalsbeek A, Fliers E. Regulatory aspects of the human hypothalamus-pituitary-thyroid axis. Best Pract Res Clin Endocrinol Metabol. 2017;31:487\u2013503.","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"618_CR12","first-page":"1","volume":"1","author":"RA Sinha","year":"2024","unstructured":"Sinha RA, Bruinstroop E, Yen PM. Actions of thyroid hormones and thyromimetics on the liver. Nat Rev Gastroenterol Hepatol. 2024;1:1.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"618_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s42255-024-00986-0","volume":"6","author":"RA Sinha","year":"2024","unstructured":"Sinha RA, Yen PM. Metabolic Messengers: Thyroid Hormones. Nat Metabol. 2024;6:639\u201350.","journal-title":"Nat Metabol"},{"key":"618_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1210\/endrev\/bnz008","volume":"41","author":"S Groeneweg","year":"2019","unstructured":"Groeneweg S, van Geest FS, Peeters RP, Heuer H, Visser WE. Thyroid Hormone Transporters. Endocr Rev. 2019;41:146\u2013201.","journal-title":"Endocr Rev"},{"key":"618_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/me.2010-0095","volume":"25","author":"WE Visser","year":"2011","unstructured":"Visser WE, Friesema EC, Visser TJ. Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol. 2011;25:1\u201314.","journal-title":"Mol Endocrinol"},{"key":"618_CR16","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1210\/er.2008-0019","volume":"29","author":"B Gereben","year":"2008","unstructured":"Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Ze\u00f6ld A, Bianco AC. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev. 2008;29:898\u2013938.","journal-title":"Endocr Rev"},{"key":"618_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2008.04.007","volume":"289","author":"U Schweizer","year":"2008","unstructured":"Schweizer U, Weitzel JM, Schomburg L. Think globally: act locally New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas. Mol Cell Endocrinol. 2008;289:1\u20139.","journal-title":"Mol Cell Endocrinol"},{"key":"618_CR18","first-page":"162","volume":"1","author":"SC Russo","year":"2021","unstructured":"Russo SC, Salas-Lucia F, Bianco AC. Deiodinases and the Metabolic Code for Thyroid Hormone Action. Endocrinology. 2021;1:162.","journal-title":"Endocrinology"},{"key":"618_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00018-007-7396-0","volume":"65","author":"B Gereben","year":"2008","unstructured":"Gereben B, Ze\u00f6ld A, Dentice M, Salvatore D, Bianco AC. Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences. Cell Mol Life Sci. 2008;65:570\u201390.","journal-title":"Cell Mol Life Sci"},{"key":"618_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1210\/edrv.23.1.0455","volume":"23","author":"AC Bianco","year":"2002","unstructured":"Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002;23:38\u201389.","journal-title":"Endocr Rev"},{"key":"618_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/JOE-11-0002","volume":"209","author":"M Dentice","year":"2011","unstructured":"Dentice M, Salvatore D. Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation. J Endocrinol. 2011;209:273\u201382.","journal-title":"J Endocrinol"},{"key":"618_CR22","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1210\/en.2017-00250","volume":"158","author":"F Flamant","year":"2017","unstructured":"Flamant F, Cheng SY, Hollenberg AN, Moeller LC, Samarut J, Wondisford FE, Yen PM, Refetoff S. Thyroid Hormone Signaling Pathways: Time for a More Precise Nomenclature. Endocrinology. 2017;158:2052\u20137.","journal-title":"Endocrinology"},{"key":"618_CR23","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI60047","volume":"122","author":"GA Brent","year":"2012","unstructured":"Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122:3035\u201343.","journal-title":"J Clin Invest"},{"key":"618_CR24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","volume":"81","author":"PM Yen","year":"2001","unstructured":"Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001;81:1097\u2013142.","journal-title":"Physiol Rev"},{"key":"618_CR25","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrendo.2014.143","volume":"10","author":"TM Ortiga-Carvalho","year":"2014","unstructured":"Ortiga-Carvalho TM, Sidhaye AR, Wondisford FE. Thyroid hormone receptors and resistance to thyroid hormone disorders. Nat Rev Endocrinol. 2014;10:582\u201391.","journal-title":"Nat Rev Endocrinol"},{"key":"618_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/er.2009-0007","volume":"31","author":"SY Cheng","year":"2010","unstructured":"Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31:139\u201370.","journal-title":"Endocr Rev"},{"key":"618_CR27","doi-asserted-by":"publisher","first-page":"e020","DOI":"10.1621\/nrs.04020","volume":"4","author":"LC Moeller","year":"2006","unstructured":"Moeller LC, Cao X, Dumitrescu AM, Seo H, Refetoff S. Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor beta through the phosphatidylinositol 3-kinase pathway. Nucl Recept Signal. 2006;4:e020.","journal-title":"Nucl Recept Signal"},{"key":"618_CR28","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1042\/bj2610945","volume":"261","author":"C Horst","year":"1989","unstructured":"Horst C, Rokos H, Seitz HJ. Rapid stimulation of hepatic oxygen consumption by 3,5-di-iodo-L-thyronine. Biochem J. 1989;261:945\u201350.","journal-title":"Biochem J"},{"key":"618_CR29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1089\/thy.2005.15.905","volume":"15","author":"DL St Germain","year":"2005","unstructured":"St Germain DL, Hernandez A, Schneider MJ, Galton VA. Insights into the role of deiodinases from studies of genetically modified animals. Thyroid. 2005;15:905\u201316.","journal-title":"Thyroid"},{"key":"618_CR30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1089\/thy.2005.15.823","volume":"15","author":"VA Galton","year":"2005","unstructured":"Galton VA. The roles of the iodothyronine deiodinases in mammalian development. Thyroid. 2005;15:823\u201334.","journal-title":"Thyroid"},{"key":"618_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ncpendmet0727","volume":"4","author":"SA Huang","year":"2008","unstructured":"Huang SA, Bianco AC. Reawakened interest in type III iodothyronine deiodinase in critical illness and injury. Nat Clin Pract Endocrinol Metabol. 2008;4:148\u201355.","journal-title":"Nat Clin Pract Endocrinol Metabol"},{"key":"618_CR32","first-page":"975","volume":"118","author":"WS Simonides","year":"2008","unstructured":"Simonides WS, Mulcahey MA, Redout EM, Muller A, Zuidwijk MJ, Visser TJ, Wassen FW, Crescenzi A, da Silva WS, Harney J, et al. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J Clin Invest. 2008;118:975\u201383.","journal-title":"J Clin Invest"},{"key":"618_CR33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2337\/db22-0656","volume":"72","author":"Y Ma","year":"2023","unstructured":"Ma Y, Shen S, Yan Y, Zhang S, Liu S, Tang Z, Yu J, Ma M, Niu Z, Li Z, et al. Adipocyte Thyroid Hormone \u03b2 Receptor-Mediated Hormone Action Fine-tunes Intracellular Glucose and Lipid Metabolism and Systemic Homeostasis. Diabetes. 2023;72:562\u201374.","journal-title":"Diabetes"},{"key":"618_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1089\/thy.1997.7.115","volume":"7","author":"LG D'Alecy","year":"1997","unstructured":"D\u2019Alecy LG. Thyroid hormone in neural rescue. Thyroid. 1997;7:115\u201324.","journal-title":"Thyroid"},{"key":"618_CR35","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1038\/s41467-022-31154-1","volume":"13","author":"S Liu","year":"2022","unstructured":"Liu S, Shen S, Yan Y, Sun C, Lu Z, Feng H, Ma Y, Tang Z, Yu J, Wu Y, et al. Triiodothyronine (T3) promotes brown fat hyperplasia via thyroid hormone receptor \u03b1 mediated adipocyte progenitor cell proliferation. Nat Commun. 2022;13:3394.","journal-title":"Nat Commun"},{"key":"618_CR36","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1210\/endo.130.5.1572286","volume":"130","author":"M Prati","year":"1992","unstructured":"Prati M, Calvo R, Morreale G, Morreale Escobar G. L-thyroxine and 3,5,3\u2019-triiodothyronine concentrations in the chicken egg and in the embryo before and after the onset of thyroid function. Endocrinology. 1992;130:2651\u20139.","journal-title":"Endocrinology"},{"key":"618_CR37","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s12020-020-02457-4","volume":"72","author":"A Tropeano","year":"2021","unstructured":"Tropeano A, Roszkowska AM, Aversa T, Corica D, Pepe G, Aragona P, Wasniewska M. Ocular morphology development and function in children with congenital hypothyroidism diagnosed by neonatal screening. Endocrine. 2021;72:932\u20136.","journal-title":"Endocrine"},{"key":"618_CR38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.exer.2009.07.007","volume":"89","author":"KE Beazley","year":"2009","unstructured":"Beazley KE, Canner JP, Linsenmayer TF. Developmental regulation of the nuclear ferritoid\u2013ferritin complex of avian corneal epithelial cells: Roles of systemic factors and thyroxine. Exp Eye Res. 2009;89:854\u201362.","journal-title":"Exp Eye Res"},{"key":"618_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mce.2016.01.018","volume":"424","author":"AM Houbrechts","year":"2016","unstructured":"Houbrechts AM, Vergauwen L, Bagci E, Van Houcke J, Heijlen M, Kulemeka B, Hyde DR, Knapen D, Darras VM. Deiodinase knockdown affects zebrafish eye development at the level of gene expression, morphology and function. Mol Cell Endocrinol. 2016;424:81\u201393.","journal-title":"Mol Cell Endocrinol"},{"key":"618_CR40","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1073\/pnas.0509981103","volume":"103","author":"MR Roberts","year":"2006","unstructured":"Roberts MR, Srinivas M, Forrest D, Morreale Escobar G, Reh TA. Making the gradient: thyroid hormone regulates cone opsin expression in the developing mouse retina. Proc Nat Acad Sci United States Am. 2006;103:6218\u201323.","journal-title":"Proc Nat Acad Sci United States Am"},{"key":"618_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000055682","volume":"33","author":"MJ Gamborino","year":"2001","unstructured":"Gamborino MJ, Sevilla-Romero E, Mu\u00f1oz A, Hern\u00e1ndez-Yago J, Renau-Piqueras J, Pinazo-Dur\u00e1n MD. Role of Thyroid Hormone in Craniofacial and Eye Development Using a Rat Model. Ophthalm Res. 2001;33:283\u201391.","journal-title":"Ophthalm Res"},{"key":"618_CR42","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1017\/S1355617713001136","volume":"19","author":"N Simic","year":"2013","unstructured":"Simic N, Khan S, Rovet J. Visuospatial, Visuoperceptual, and Visuoconstructive Abilities in Congenital Hypothyroidism. J Int Neuropsychol Soc. 2013;19:1119\u201327.","journal-title":"J Int Neuropsychol Soc"},{"key":"618_CR43","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1203\/01.PDR.0000157681.38042.B4","volume":"57","author":"G Mirabella","year":"2005","unstructured":"Mirabella G, Westall CA, Asztalos E, Perlman K, Koren G, Rovet J. Development of Contrast Sensitivity in Infants with Prenatal and Neonatal Thyroid Hormone Insufficiencies. Pediatric Res. 2005;57:902\u20137.","journal-title":"Pediatric Res"},{"key":"618_CR44","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2307\/1540499","volume":"151","author":"JP Durand","year":"1976","unstructured":"Durand JP. Ocular Development and Involution in the European Cave Salamander Proteus Anguinus Laurenti. Biol Bull. 1976;151:450\u201366.","journal-title":"Biol Bull"},{"key":"618_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2022.837687","volume":"13","author":"A Cohen","year":"2022","unstructured":"Cohen A, Popowitz J, Delbridge-Perry M, Rowe CJ, Connaughton VP. The Role of Estrogen and Thyroid Hormones in Zebrafish Visual System Function. Front Pharmacol. 2022;13:1.","journal-title":"Front Pharmacol"},{"key":"618_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainres.2011.04.005","volume":"1392","author":"MD Pinazo-Dur\u00e1n","year":"2011","unstructured":"Pinazo-Dur\u00e1n MD, Pons-V\u00e1zquez S, Gallego-Pinazo R, Galbis Estrada C, Zan\u00f3n-Moreno V, Vila Bou V, Sanz Solana P. Thyroid hormone deficiency disrupts rat eye neurodevelopment. Brain Res. 2011;1392:16\u201326.","journal-title":"Brain Res"},{"key":"618_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/83829","volume":"27","author":"L Ng","year":"2001","unstructured":"Ng L, Hurley JB, Dierks B, Srinivas M, Salt\u00f3 C, Vennstr\u00f6m B, Reh TA, Forrest D. A thyroid hormone receptor that is required for the development of green cone photoreceptors. Nat Genet. 2001;27:94\u20138.","journal-title":"Nat Genet"},{"key":"618_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1471-213X-8-101","volume":"8","author":"JM Trimarchi","year":"2008","unstructured":"Trimarchi JM, Harpavat S, Billings NA, Cepko CL. Thyroid hormone components are expressed in three sequential waves during development of the chick retina. BMC Dev Biol. 2008;8:101.","journal-title":"BMC Dev Biol"},{"key":"618_CR49","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1523\/JNEUROSCI.6181-10.2011","volume":"31","author":"A Glaschke","year":"2011","unstructured":"Glaschke A, Weiland J, Del Turco D, Steiner M, Peichl L, Gl\u00f6smann M. Thyroid Hormone Controls Cone Opsin Expression in the Retina of Adult Rodents. J Neurosci. 2011;31:4844\u201351.","journal-title":"J Neurosci"},{"key":"618_CR50","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1089\/105072503770867183","volume":"13","author":"S Harpavat","year":"2003","unstructured":"Harpavat S, Cepko CL. Thyroid hormone and retinal development: an emerging field. Thyroid: Off J Am Thyroid Assoc. 2003;13:1013\u20139.","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"618_CR51","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1167\/iovs.09-3592","volume":"51","author":"A Glaschke","year":"2010","unstructured":"Glaschke A, Gl\u00f6smann M, Peichl L. Developmental Changes of Cone Opsin Expression but Not Retinal Morphology in the Hypothyroid Pax8 Knockout Mouse. Invest Opthalmol Vis Sci. 2010;51:1719.","journal-title":"Invest Opthalmol Vis Sci"},{"key":"618_CR52","first-page":"1280","volume":"36","author":"MW Kelley","year":"1995","unstructured":"Kelley MW, Turner JK, Reh TA. Regulation of proliferation and photoreceptor differentiation in fetal human retinal cell cultures. Invest Ophthalmol Vis Sci. 1995;36:1280\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR53","doi-asserted-by":"publisher","first-page":"16882","DOI":"10.1073\/pnas.1904783116","volume":"116","author":"RD Mackin","year":"2019","unstructured":"Mackin RD, Frey RA, Gutierrez C, Farre AA, Kawamura S, Mitchell DM, Stenkamp DL. Endocrine regulation of multichromatic color vision. Proc Nat Acad Sci. 2019;116:16882\u201391.","journal-title":"Proc Nat Acad Sci"},{"key":"618_CR54","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0165-3806(94)90315-8","volume":"81","author":"A Guada\u00f1o Ferraz","year":"1994","unstructured":"Guada\u00f1o Ferraz A, Escobar Rey F, Morreale Escobar G, Innocenti GM, Berbel P. The development of the anterior commissure in normal and hypothyroid rats. Brain Res Dev Brain Res. 1994;81:293\u2013308.","journal-title":"Brain Res Dev Brain Res"},{"key":"618_CR55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/(SICI)1521-1878(200001)22:1<64::AID-BIES11>3.0.CO;2-Q","volume":"22","author":"B Durand","year":"2000","unstructured":"Durand B, Raff M. A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays. 2000;22:64\u201371.","journal-title":"Bioessays"},{"key":"618_CR56","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1006\/dbio.1999.9397","volume":"213","author":"YM Tokumoto","year":"1999","unstructured":"Tokumoto YM, Durand B, Raff MC. An analysis of the early events when oligodendrocyte precursor cells are triggered to differentiate by thyroid hormone, retinoic acid, or PDGF withdrawal. Dev Biol. 1999;213:327\u201339.","journal-title":"Dev Biol"},{"key":"618_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/15569527.2015.1007509","volume":"35","author":"T Kocaturk","year":"2016","unstructured":"Kocaturk T, Ergin K, Cesur G, Evlicoglu GE, Cakmak H. The effect of methimazole-induced postnatal hypothyroidism on the retinal maturation and on the Sirtuin 2 level. Cutan Ocul Toxicol. 2016;35:36\u201340.","journal-title":"Cutan Ocul Toxicol"},{"key":"618_CR58","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1523\/JNEUROSCI.5267-09.2010","volume":"30","author":"L Ng","year":"2010","unstructured":"Ng L, Lyubarsky A, Nikonov SS, Ma M, Srinivas M, Kefas B, Germain DLS, Hernandez A, Pugh EN, Forrest D. Type 3 Deiodinase, a Thyroid-Hormone-Inactivating Enzyme, Controls Survival and Maturation of Cone Photoreceptors. J Neurosci. 2010;30:3347\u201357.","journal-title":"J Neurosci"},{"key":"618_CR59","doi-asserted-by":"publisher","first-page":"12215","DOI":"10.3390\/ijms252212215","volume":"25","author":"I Lazcano","year":"2024","unstructured":"Lazcano I, Pech-Pool SM, Maldonado-Lira MF, Olvera A, Darras VM, Orozco A. Ontogeny of Thyroid Hormone Signaling in the Retina of Zebrafish: Effects of Thyroidal Status on Retinal Morphology, Cell Survival, and Color Preference. Int J Mol Sciences. 2024;25:12215.","journal-title":"Int J Mol Sciences"},{"key":"618_CR60","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1210\/en.2008-1419","volume":"150","author":"L Ng","year":"2009","unstructured":"Ng L, Hernandez A, He W, Ren T, Srinivas M, Ma M, Galton VA, St. Germain DL, Forrest D. A Protective Role for Type 3 Deiodinase, a Thyroid Hormone-Inactivating Enzyme, in Cochlear Development and Auditory Function. Endocrinology. 2009;150:1952\u201360.","journal-title":"Endocrinology"},{"key":"618_CR61","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/dvdy.21155","volume":"236","author":"ML Applebury","year":"2007","unstructured":"Applebury ML, Farhangfar F, Gl\u00f6smann M, Hashimoto K, Kage K, Robbins JT, Shibusawa N, Wondisford FE, Zhang H. Transient expression of thyroid hormone nuclear receptor TRbeta2 sets S opsin patterning during cone photoreceptor genesis. Dev Dyn: Off Publ Am Assoc Anatom. 2007;236:1203\u201312.","journal-title":"Dev Dyn: Off Publ Am Assoc Anatom"},{"key":"618_CR62","doi-asserted-by":"publisher","first-page":"11118","DOI":"10.1523\/JNEUROSCI.1709-11.2011","volume":"31","author":"L Ng","year":"2011","unstructured":"Ng L, Lu A, Swaroop A, Sharlin DS, Swaroop A, Forrest D. Two transcription factors can direct three photoreceptor outcomes from rod precursor cells in mouse retinal development. J Neurosci: Off J Soc Neurosci. 2011;31:11118\u201325.","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"618_CR63","doi-asserted-by":"publisher","first-page":"15262","DOI":"10.1073\/pnas.1920086117","volume":"117","author":"LI Volkov","year":"2020","unstructured":"Volkov LI, Kim-Han JS, Saunders LM, Poria D, Hughes AEO, Kefalov VJ, Parichy DM, Corbo JC. Thyroid hormone receptors mediate two distinct mechanisms of long-wavelength vision. Proc Nat Acad Sci United States Am. 2020;117:15262\u20139.","journal-title":"Proc Nat Acad Sci United States Am"},{"key":"618_CR64","doi-asserted-by":"publisher","first-page":"15109","DOI":"10.1073\/pnas.1303551110","volume":"110","author":"SC Suzuki","year":"2013","unstructured":"Suzuki SC, Bleckert A, Williams PR, Takechi M, Kawamura S, Wong ROL. Cone photoreceptor types in zebrafish are generated by symmetric terminal divisions of dedicated precursors. Proc Nat Acad Sci. 2013;110:15109\u201314.","journal-title":"Proc Nat Acad Sci"},{"key":"618_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2023.1174600","volume":"14","author":"L Ng","year":"2023","unstructured":"Ng L, Liu H, Liu Y, Forrest D. Biphasic expression of thyroid hormone receptor TR\u03b21 in mammalian retina and anterior ocular tissues. Front Endocrinol. 2023;14:1.","journal-title":"Front Endocrinol"},{"key":"618_CR66","doi-asserted-by":"publisher","first-page":"e2402560121","DOI":"10.1073\/pnas.2402560121","volume":"121","author":"Y Liu","year":"2024","unstructured":"Liu Y, Ng L, Liu H, Heuer H, Forrest D. Cone photoreceptor differentiation regulated by thyroid hormone transporter MCT8 in the retinal pigment epithelium. Proc Nat Acad Sci. 2024;121:e2402560121.","journal-title":"Proc Nat Acad Sci"},{"key":"618_CR67","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1017\/S0952523804216145","volume":"21","author":"WT Allison","year":"2004","unstructured":"Allison WT, Haimberger TJ, Hawryshyn CW, Temple SE. Visual pigment composition in zebrafish: Evidence for a rhodopsin\u2013porphyropsin interchange system. Vis Neurosci. 2004;21:945\u201352.","journal-title":"Vis Neurosci"},{"key":"618_CR68","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1016\/j.cub.2015.10.018","volume":"25","author":"JM Enright","year":"2015","unstructured":"Enright JM, Toomey MB, Sato S, Temple SE, Allen JR, Fujiwara R, Kramlinger VM, Nagy LD, Johnson KM, Xiao Y, et al. Cyp27c1 Red-Shifts the Spectral Sensitivity of Photoreceptors by Converting Vitamin A1 into A2. Cur Biol. 2015;25:3048\u201357.","journal-title":"Cur Biol"},{"key":"618_CR69","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.aquatox.2015.12.015","volume":"172","author":"L Baumann","year":"2016","unstructured":"Baumann L, Ros A, Rehberger K, Neuhauss SCF, Segner H. Thyroid disruption in zebrafish (Danio rerio) larvae: Different molecular response patterns lead to impaired eye development and visual functions. Aquat Toxicol. 2016;172:44\u201355.","journal-title":"Aquat Toxicol"},{"key":"618_CR70","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0014-4835(64)80024-5","volume":"3","author":"AJ Coulombre","year":"1964","unstructured":"Coulombre AJ, Coulombre JL. Corneal development: III. The role of the thyroid in dehydration and the development of transparency. Exp Eye Res. 1964;3:105\u201314.","journal-title":"Exp Eye Res"},{"key":"618_CR71","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1167\/iovs.07-0800","volume":"49","author":"AH Conrad","year":"2008","unstructured":"Conrad AH, Strafuss JM, Wittman MD, Conway S, Conrad GW. Thyroxine Increases the Rate but Does Not Alter the Pattern of Innervation during Embryonic Chick Corneal Development. Invest Ophthalmol Vis Sci. 2008;49:139\u201353.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR72","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0012-1606(75)90023-8","volume":"43","author":"E Masterson","year":"1975","unstructured":"Masterson E, Edelhauser HF, Van Horn DL. Development of corneal transparency in embryonic chick: influence of exogenous thyroxine and thiouracil on structure, water and electrolyte content. Dev Biol. 1975;43:233\u20139.","journal-title":"Dev Biol"},{"key":"618_CR73","first-page":"105","volume":"16","author":"E Masterson","year":"1977","unstructured":"Masterson E, Edelhauser HF, Van Horn DL. The role of thyroid hormone in the development of the chick corneal endothelium and epithelium. Invest Ophthalmol Vis Sci. 1977;16:105\u201315.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR74","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1167\/iovs.05-0806","volume":"47","author":"AH Conrad","year":"2006","unstructured":"Conrad AH, Zhang Y, Walker AR, Olberding LA, Hanzlick A, Zimmer AJ, Morffi R, Conrad GW. Thyroxine Affects Expression of KSPG-Related Genes, the Carbonic Anhydrase II Gene, and KS Sulfation in the Embryonic Chicken Cornea. Invest Opthalmol Vis Sci. 2006;47:120.","journal-title":"Invest Opthalmol Vis Sci"},{"key":"618_CR75","doi-asserted-by":"publisher","first-page":"108007","DOI":"10.1016\/j.exer.2020.108007","volume":"194","author":"M Patel","year":"2020","unstructured":"Patel M, Pham NTK, Ziegenhorn E, Pisano A, Deaton RJ, Kim S, Rajarathnam V, Schwend T. Unique and overlapping effects of triiodothyronine (T3) and thyroxine (T4) on sensory innervation of the chick cornea. Exp Eye Res. 2020;194:108007.","journal-title":"Exp Eye Res"},{"key":"618_CR76","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1006\/exer.2001.0997","volume":"72","author":"H Kosano","year":"2001","unstructured":"Kosano H, Watanabe H, Nishigori H. Suppressive Effects of Thyroxine on Glucocorticoid (GC)-induced Metabolic Changes and Cataract Formation on Developing Chick Embryos. Exp Eye Res. 2001;72:643\u20138.","journal-title":"Exp Eye Res"},{"key":"618_CR77","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1167\/iovs.06-0908","volume":"48","author":"L Huang","year":"2007","unstructured":"Huang L, Yappert MC, Miller JJ, Borchman D. Thyroxine Ameliorates Oxidative Stress by Inducing Lipid Compositional Changes in Human Lens Epithelial Cells. Invest Opthalmol Vis Sci. 2007;48:3698.","journal-title":"Invest Opthalmol Vis Sci"},{"key":"618_CR78","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/02713680802167554","volume":"33","author":"L Huang","year":"2008","unstructured":"Huang L, Yappert MC, Jumblatt MM, Borchman D. Hyperoxia and Thyroxine Treatment and the Relationships between Reactive Oxygen Species Generation, Mitochondrial Membrane Potential, and Cardiolipin in Human Lens Epithelial Cell Cultures. Cur Eye Res. 2008;33:575\u201386.","journal-title":"Cur Eye Res"},{"key":"618_CR79","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3928\/1081597X-20210105-03","volume":"37","author":"RM Bassiouny","year":"2021","unstructured":"Bassiouny RM, Awad EA, Gaafar W, Kyrillos FA, Abou Samra WA, Abdelhameed AG. Corneal Tomographic Analysis Among Patients With Thyroid Gland Dysfunction. J Refract Surg. 2021;37:192\u20137.","journal-title":"J Refract Surg"},{"key":"618_CR80","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1177\/112067210501500506","volume":"15","author":"UA Bah\u00e7eci","year":"2005","unstructured":"Bah\u00e7eci UA, Ozdek S, Pehlivanli Z, Yetkin I, Onol M. Changes in intraocular pressure and corneal and retinal nerve fiber layer thicknesses in hypothyroidism. Eur J Ophthalmol. 2005;15:556\u201361.","journal-title":"Eur J Ophthalmol"},{"key":"618_CR81","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3928\/1081597X-20200226-03","volume":"36","author":"A El-Massry","year":"2020","unstructured":"El-Massry A, Doheim MF, Iqbal M, Fawzy O, Said OM, Yousif MO, Badawi AE, Tawfik A, Abousamra A. Association Between Keratoconus and Thyroid Gland Dysfunction: A Cross-Sectional Case-Control Study. J Refract Surg. 2020;36:253\u20137.","journal-title":"J Refract Surg"},{"key":"618_CR82","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3928\/1081597X-20171031-02","volume":"34","author":"R Lee","year":"2018","unstructured":"Lee R, Hafezi F, Randleman JB. Bilateral Keratoconus Induced by Secondary Hypothyroidism After Radioactive Iodine Therapy. J Refract Surg. 2018;34:351\u20133.","journal-title":"J Refract Surg"},{"key":"618_CR83","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1097\/ICO.0000000000000988","volume":"35","author":"S Thanos","year":"2016","unstructured":"Thanos S, Oellers P, Meyer Zu MH, Prokosch V, Schlatt S, Seitz B, Gatzioufas Z. Role of Thyroxine in the Development of Keratoconus. Cornea. 2016;35:1338\u201346.","journal-title":"Cornea"},{"key":"618_CR84","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1080\/02713683.2016.1256413","volume":"42","author":"T Stachon","year":"2017","unstructured":"Stachon T, Stachon A, Hartmann U, Seitz B, Langenbucher A, Szentm\u00e1ry N. Urea, Uric Acid, Prolactin and fT4 Concentrations in Aqueous Humor of Keratoconus Patients. Curr Eye Res. 2017;42:842\u20136.","journal-title":"Curr Eye Res"},{"key":"618_CR85","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3928\/1081597X-20180301-02","volume":"34","author":"R Lee","year":"2018","unstructured":"Lee R, El-Massry A, El-Massry Y, Randleman JB. Bilateral, Asymmetric Keratoconus Induced by Thyrotoxicosis With Long-term Stability After Corneal Cross-linking. J Refract Surg. 2018;34:354\u20136.","journal-title":"J Refract Surg"},{"key":"618_CR86","first-page":"1","volume":"11","author":"M Babi\u0107 Leko","year":"2022","unstructured":"Babi\u0107 Leko M, Plei\u0107 N, Le\u0161in M, Gunja\u010da I, Torlak V, \u0160kunca Herman J, Vatavuk Z, Punda A, Pola\u0161ek O, Hayward C, Zemunik T. Association between Thyroid Function and Ocular Parameters. Biology (Basel). 2022;11:1.","journal-title":"Biology (Basel)"},{"key":"618_CR87","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/02713683.2021.1967403","volume":"47","author":"T Stachon","year":"2022","unstructured":"Stachon T, Omar Ali M, Latta L, Huessein GH, Mohamed TA, Soliman W, Seitz B, Szentm\u00e1ry N. Effect of Thyroxine on Transforming Growth Factor \u03b21, Collagen I, and V Expression in Keratoconus Corneal Fibroblasts and Keratocytes, in Vitro. Curr Eye Res. 2022;47:206\u201313.","journal-title":"Curr Eye Res"},{"key":"618_CR88","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0014-4835(90)90134-G","volume":"50","author":"IL Kah\u00e1n","year":"1990","unstructured":"Kah\u00e1n IL, Vars\u00e1nyi-Nagy M, T\u00f3th M, N\u00e1drai A. The possible role of tear fluid thyroxine in keratoconus development. Exp Eye Res. 1990;50:339\u201343.","journal-title":"Exp Eye Res"},{"key":"618_CR89","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.4103\/IJO.IJO_2887_22","volume":"71","author":"B Gorimanipalli","year":"2023","unstructured":"Gorimanipalli B, Khamar P, Sethu S, Shetty R. Hormones and dry eye disease. Indian J Ophthalmol. 2023;71:1276\u201384.","journal-title":"Indian J Ophthalmol"},{"key":"618_CR90","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12886-018-0763-9","volume":"18","author":"CY Wang","year":"2018","unstructured":"Wang CY, Ho RW, Fang PC, Yu HJ, Chien CC, Hsiao CC, Kuo MT. The function and morphology of Meibomian glands in patients with thyroid eye disease: a preliminary study. BMC Ophthalmol. 2018;18:90.","journal-title":"BMC Ophthalmol"},{"key":"618_CR91","doi-asserted-by":"publisher","first-page":"e800","DOI":"10.1111\/aos.14000","volume":"97","author":"J Park","year":"2019","unstructured":"Park J, Baek S. Dry eye syndrome in thyroid eye disease patients: The role of increased incomplete blinking and Meibomian gland loss. Acta Ophthalmol. 2019;97:e800-6.","journal-title":"Acta Ophthalmol"},{"key":"618_CR92","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jcjo.2017.11.006","volume":"53","author":"J Park","year":"2018","unstructured":"Park J, Kim J, Lee H, Park M, Baek S. Functional and structural evaluation of the meibomian gland using a LipiView interferometer in thyroid eye disease. Canad J Ophthalmol. 2018;53:373\u20139.","journal-title":"Canad J Ophthalmol"},{"key":"618_CR93","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jcjo.2015.05.012","volume":"50","author":"YS Kim","year":"2015","unstructured":"Kim YS, Kwak AY, Lee SY, Yoon JS, Jang SY. Meibomian gland dysfunction in Graves\u2019 orbitopathy. Canad J Ophthalmol. 2015;50:278\u201382.","journal-title":"Canad J Ophthalmol"},{"key":"618_CR94","doi-asserted-by":"publisher","first-page":"e0250617","DOI":"10.1371\/journal.pone.0250617","volume":"16","author":"V Satitpitakul","year":"2021","unstructured":"Satitpitakul V, Rattanaphong T, Pruksakorn V. Meibomian glands dropout in patients with inactive thyroid related orbitopathy. PLoS One. 2021;16:e0250617.","journal-title":"PLoS One"},{"key":"618_CR95","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/08820538.2013.874491","volume":"30","author":"A Bruscolini","year":"2015","unstructured":"Bruscolini A, Abbouda A, Locuratolo N, Restivo L, Trimboli P, Romanelli F. Dry Eye Syndrome in Non-Exophthalmic Graves\u2019 Disease. Semin Ophthalmol. 2015;30:372\u20136.","journal-title":"Semin Ophthalmol"},{"key":"618_CR96","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1167\/iovs.06-1309","volume":"48","author":"AC Dias","year":"2007","unstructured":"Dias AC, M\u00f3dulo CM, Jorge AG, Braz AM, Jord\u00e3o AA Jr, Filho RB, de Paula JS, Rocha EM. Influence of thyroid hormone on thyroid hormone receptor beta-1 expression and lacrimal gland and ocular surface morphology. Invest Ophthalmol Vis Sci. 2007;48:3038\u201342.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR97","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2460\/javma.233.11.1761","volume":"233","author":"BC Schwarz","year":"2008","unstructured":"Schwarz BC, Sallmutter T, Nell B. Keratoconjunctivitis sicca attributable to parasympathetic facial nerve dysfunction associated with hypothyroidism in a horse. J Am Vet Med Assoc. 2008;233:1761\u20136.","journal-title":"J Am Vet Med Assoc"},{"key":"618_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/aja.1001150102","volume":"115","author":"R Carriere","year":"1964","unstructured":"Carriere R. The influence of the thyroid gland on polyploid cell formation in the external orbital gland of the rat. Am J Anatom. 1964;115:1\u201315.","journal-title":"Am J Anatom"},{"key":"618_CR99","first-page":"277","volume":"7","author":"A Nover","year":"1957","unstructured":"Nover A. Effect of testosterone and hypophysin on tear secretion. Arzneimittel-Forschung. 1957;7:277\u20138.","journal-title":"Arzneimittel-Forschung"},{"key":"618_CR100","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1395-3907.2004.00268.x","volume":"82","author":"AK Eckstein","year":"2004","unstructured":"Eckstein AK, Finkenrath A, Heiligenhaus A, Renzing-K\u00f6hler K, Esser J, Kr\u00fcger C, Quadbeck B, Steuhl KP, Gieseler RK. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand. 2004;82:291\u20137.","journal-title":"Acta Ophthalmol Scand"},{"key":"618_CR101","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1136\/bjo.2008.147165","volume":"92","author":"JM Cross","year":"2008","unstructured":"Cross JM, Girkin CA, Owsley C, McGwin G. The Association between Thyroid Problems and Glaucoma. Br J Ophthalmol. 2008;92:1503\u20135.","journal-title":"Br J Ophthalmol"},{"key":"618_CR102","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/aos.13412","volume":"95","author":"M Thvilum","year":"2017","unstructured":"Thvilum M, Brandt F, Brix TH, Heged\u00fcs L. The interrelation between hypothyroidism and glaucoma: a critical review and meta-analyses. Acta Ophthalmol. 2017;95:759\u201367.","journal-title":"Acta Ophthalmol"},{"key":"618_CR103","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4103\/IJO.IJO_603_23","volume":"72","author":"S Unnikrishnan","year":"2024","unstructured":"Unnikrishnan S, Anilakumari VP, Mohammed F. Subclinical hypothyroidism and anti-thyroid peroxidase antibodies in primary open-angle glaucoma: A case\u2013control study. Indian J Ophthalmol. 2024;72:228.","journal-title":"Indian J Ophthalmol"},{"key":"618_CR104","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/S0161-6420(93)31441-7","volume":"100","author":"KD Smith","year":"1993","unstructured":"Smith KD, Arthurs BP, Saheb N. An association between hypothyroidism and primary open-angle glaucoma. Ophthalmology. 1993;100:1580\u20134.","journal-title":"Ophthalmology"},{"key":"618_CR105","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0002-9394(00)00724-8","volume":"131","author":"P Karadimas","year":"2001","unstructured":"Karadimas P, Bouzas EA, Topouzis F, Koutras DA, Mastorakos G. Hypothyroidism and glaucoma a study of 100 hypothyroid patients. Am J Ophthalmol. 2001;131:126\u20138.","journal-title":"Am J Ophthalmol"},{"key":"618_CR106","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.ophtha.2004.05.026","volume":"111","author":"CA Girkin","year":"2004","unstructured":"Girkin CA, McGwin G, McNeal SF, Lee PP, Owsley C. Hypothyroidism and the development of open-angle glaucoma in a male population. Ophthalmology. 2004;111:1649\u201352.","journal-title":"Ophthalmology"},{"key":"618_CR107","first-page":"341","volume":"27","author":"KD Smith","year":"1992","unstructured":"Smith KD, Tevaarwerk GJ, Allen LH. An ocular dynamic study supporting the hypothesis that hypothyroidism is a treatable cause of secondary open-angle glaucoma. Canad J Ophthalmol J Canad D\u2019ophtalmol. 1992;27:341\u20134.","journal-title":"Canad J Ophthalmol J Canad D'ophtalmol"},{"key":"618_CR108","doi-asserted-by":"publisher","first-page":"e0192311","DOI":"10.1371\/journal.pone.0192311","volume":"13","author":"M Thvilum","year":"2018","unstructured":"Thvilum M, Brandt F, Brix TH, Heged\u00fcs L. No evidence of a causal relationship between hypothyroidism and glaucoma: A Danish nationwide register-based cohort study. PLoS One. 2018;13:e0192311.","journal-title":"PLoS One"},{"key":"618_CR109","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/bjo.2010.195032","volume":"95","author":"J Calissendorff","year":"2011","unstructured":"Calissendorff J, Ljung R. Thyroxin substitution and open-angle glaucoma: a nationwide register-based study on filled prescriptions. Br J Ophthalmol. 2011;95:592\u20134.","journal-title":"Br J Ophthalmol"},{"key":"618_CR110","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.ophtha.2008.01.016","volume":"115","author":"SP Motsko","year":"2008","unstructured":"Motsko SP, Jones JK. Is There an Association between Hypothyroidism and Open-angle Glaucoma in an Elderly Population?: An Epidemiologic Study. Ophthalmology. 2008;115:1581\u20134.","journal-title":"Ophthalmology"},{"key":"618_CR111","doi-asserted-by":"publisher","first-page":"183.e181","DOI":"10.1016\/j.amjmed.2009.06.030","volume":"123","author":"K Boelaert","year":"2010","unstructured":"Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, Manji N, Allahabadia A, Armitage M, Chatterjee KV, et al. Prevalence and Relative Risk of Other Autoimmune Diseases in Subjects with Autoimmune Thyroid Disease. Am J Med. 2010;123:183.e181-9.","journal-title":"Am J Med"},{"key":"618_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/ENDO:24:1:001","volume":"24","author":"B Biondi","year":"2004","unstructured":"Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine. 2004;24:1\u201313.","journal-title":"Endocrine"},{"key":"618_CR113","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11892-016-0815-6","volume":"16","author":"BJ Song","year":"2016","unstructured":"Song BJ, Aiello LP, Pasquale LR. Presence and Risk Factors for Glaucoma in Patients with Diabetes. Curr Diaet Reports. 2016;16:124.","journal-title":"Curr Diaet Reports"},{"key":"618_CR114","doi-asserted-by":"publisher","first-page":"e108226","DOI":"10.1371\/journal.pone.0108226","volume":"9","author":"HW Bae","year":"2014","unstructured":"Bae HW, Lee N, Lee HS, Hong S, Seong GJ, Kim CY. Systemic Hypertension as a Risk Factor for Open-Angle Glaucoma: A Meta-Analysis of Population-Based Studies. PLoS One. 2014;9:e108226.","journal-title":"PLoS One"},{"key":"618_CR115","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith TJ, Heged\u00fcs L. Graves\u2019 Disease. New England J Med. 2016;375:1552\u201365.","journal-title":"New England J Med"},{"key":"618_CR116","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/IOP.0000000000002310","volume":"39","author":"A Delavar","year":"2023","unstructured":"Delavar A, Saseendrakumar BR, Lee TC, Topilow NJ, Ting MA, Liu CY, Korn BS, Weinreb RN, Kikkawa DO, Baxter SL. Associations Between Thyroid Eye Disease and Glaucoma Among Those Enrolled in the National Institutes of Health All of Us Research Program. Ophthalm Plastic Reconstruct Surg. 2023;39:336\u201340.","journal-title":"Ophthalm Plastic Reconstruct Surg"},{"key":"618_CR117","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00417-022-05873-6","volume":"261","author":"R Ma","year":"2023","unstructured":"Ma R, Li X, Peng Z, Guo J, Qian J, Zhang Y. Using 24-h intraocular pressure-related patterns to identify open-angle glaucoma in thyroid eye disease. Graefe\u2019s Arch Clin Exp Ophthalmol. 2023;261:1151\u20138.","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"618_CR118","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0161-6420(97)30207-3","volume":"104","author":"KP Cockerham","year":"1997","unstructured":"Cockerham KP, Pal C, Jani B, Wolter A, Kennerdell JS. The Prevalence and Implications of Ocular Hypertension and Glaucoma in Thyroid-associated Orbitopathy. Ophthalmology. 1997;104:914\u20137.","journal-title":"Ophthalmology"},{"key":"618_CR119","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0002-9394(99)00473-0","volume":"129","author":"K Ohtsuka","year":"2000","unstructured":"Ohtsuka K, Nakamura Y. Open-angle glaucoma associated with Graves disease. Am J Ophthalmol. 2000;129:613\u20137.","journal-title":"Am J Ophthalmol"},{"key":"618_CR120","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41433-021-01453-w","volume":"36","author":"J Guo","year":"2022","unstructured":"Guo J, Li X, Ma R, Gan L, Qian J. The changes of retinal nerve fibre layer and ganglion cell layer with different severity of thyroid eye disease. Eye. 2022;36:129\u201334.","journal-title":"Eye"},{"key":"618_CR121","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/IOP.0000000000002049","volume":"38","author":"BK Betzler","year":"2022","unstructured":"Betzler BK, Young SM, Sundar G. Intraocular Pressure and Glaucoma in Thyroid Eye Disease. Ophthalm Plast Reconstruct Surg. 2022;38:219.","journal-title":"Ophthalm Plast Reconstruct Surg"},{"key":"618_CR122","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12020-017-1485-0","volume":"59","author":"F Brandt","year":"2018","unstructured":"Brandt F, Thvilum M, Heged\u00fcs L, Brix TH. Hyperthyroid patients without Graves\u2019 orbitopathy are not at increased risk of developing glaucoma: a nationwide Danish register-based case-control study. Endocrine. 2018;59:137\u201342.","journal-title":"Endocrine"},{"key":"618_CR123","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/sj.eye.6700731","volume":"18","author":"AJ Lee","year":"2004","unstructured":"Lee AJ, Rochtchina E, Wang JJ, Healey PR, Mitchell P. Open-angle glaucoma and systemic thyroid disease in an older population: The Blue Mountains Eye Study. Eye. 2004;18:600\u20138.","journal-title":"Eye"},{"key":"618_CR124","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s004170050224","volume":"237","author":"KG Duncan","year":"1999","unstructured":"Duncan KG, Jumper MD, Ribeiro RC, Bailey KR, Yen PM, Sugawara A, Patel A, Stern R, Chin WW, Baxter JD, Schwartz DM. Human trabecular meshwork cells as a thyroid hormone target tissue: presence of functional thyroid hormone receptors. Graefe\u2019s Arch Clin Exp Ophthalmol = Albrecht Von Graefes Archiv Fur Klinische Und Exp Ophthalmol. 1999;237:231\u201340.","journal-title":"Graefe's Arch Clin Exp Ophthalmol = Albrecht Von Graefes Archiv Fur Klinische Und Exp Ophthalmol"},{"key":"618_CR125","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1748-1716.1954.tb01092.x","volume":"30","author":"EH Barany","year":"1954","unstructured":"Barany EH, Scotchbrook S. Influence of testicular hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Physiol Scandinav. 1954;30:240\u20138.","journal-title":"Acta Physiol Scandinav"},{"key":"618_CR126","first-page":"51","volume":"76","author":"C Pedler","year":"1956","unstructured":"Pedler C. The relationship of hyaluronidase to aqueous outflow resistance. Trans Ophthalmol Soc United Kingdom. 1956;76:51\u201363.","journal-title":"Trans Ophthalmol Soc United Kingdom"},{"key":"618_CR127","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/eye.2000.137","volume":"14","author":"JR Polansky","year":"2000","unstructured":"Polansky JR, Fauss DJ, Zimmerman CC. Regulation of TIGR\/MYOC gene expression in human trabecular meshwork cells. Eye. 2000;14:503\u201314.","journal-title":"Eye"},{"key":"618_CR128","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.otc.2006.07.008","volume":"39","author":"HBH Lee","year":"2006","unstructured":"Lee HBH, Rodgers IR, Woog JJ. Evaluation and management of Graves\u2019 orbitopathy. Otolaryngol Clin North Am. 2006;39:923\u201342.","journal-title":"Otolaryngol Clin North Am"},{"key":"618_CR129","doi-asserted-by":"publisher","first-page":"e01101","DOI":"10.1002\/cti2.1101","volume":"9","author":"VM Beutgen","year":"2020","unstructured":"Beutgen VM, Schmelter C, Pfeiffer N, Grus FH. Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire. Clin Transl Immunol. 2020;9:e01101.","journal-title":"Clin Transl Immunol"},{"key":"618_CR130","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0140-6736(17)30544-5","volume":"390","author":"Y-C Liu","year":"2017","unstructured":"Liu Y-C, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. Lancet (London, England). 2017;390:600\u201312.","journal-title":"Lancet (London, England)"},{"key":"618_CR131","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s41433-020-0806-3","volume":"34","author":"H Hashemi","year":"2020","unstructured":"Hashemi H, Pakzad R, Yekta A, Aghamirsalim M, Pakbin M, Ramin S, Khabazkhoob M. Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis. Eye (London, England). 2020;34:1357\u201370.","journal-title":"Eye (London, England)"},{"key":"618_CR132","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/ageing\/afv126","volume":"44","author":"K Cooper","year":"2015","unstructured":"Cooper K, Shepherd J, Frampton G, Harris P, Lotery A. The cost-effectiveness of second-eye cataract surgery in the UK. Age Ageing. 2015;44:1026\u201331.","journal-title":"Age Ageing"},{"key":"618_CR133","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1136\/bjo.56.7.546","volume":"56","author":"RS Mahto","year":"1972","unstructured":"Mahto RS. Ocular features of hypothyroidism. Br J Ophthalmol. 1972;56:546\u20139.","journal-title":"Br J Ophthalmol"},{"key":"618_CR134","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4045\/tidsskr.12.0390","volume":"133","author":"EA Malt","year":"2013","unstructured":"Malt EA, Dahl RC, Haugsand TM, Ulvestad IH, Emilsen NM, Hansen B, Cardenas YEG, Sk\u00f8ld RO, Thorsen ATB, Davidsen EMM. Health and disease in adults with Down syndrome. Tidsskrift for Den Norske Laegeforening: Tidsskrift for Praktisk Medicin, Ny Raekke. 2013;133:290\u20134.","journal-title":"Tidsskrift for Den Norske Laegeforening: Tidsskrift for Praktisk Medicin, Ny Raekke"},{"key":"618_CR135","first-page":"1","volume":"15","author":"S Liu","year":"2024","unstructured":"Liu S, Sun Q, Gu Q, Bao Y, Wang W, Qin X, Yuan X. Hypothyroidism is a causal determinant of age-related cataract risk in European population: a Mendelian randomization study. Front Endocrinol. 2024;15:1.","journal-title":"Front Endocrinol"},{"key":"618_CR136","first-page":"24972","volume":"14","author":"H Ding","year":"2024","unstructured":"Ding H, Chen T, Peng H, Wang L, Gu J. Causal relationship between hyperthyroidism and cataracts: a two-sample bi-directional mendelian randomization study. Sci Reports. 2024;14:24972.","journal-title":"Sci Reports"},{"key":"618_CR137","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0306-9877(91)90275-4","volume":"35","author":"N Annal","year":"1991","unstructured":"Annal N. Thyroxine may cure leprosy, fungal diseases and metabolic cataract. Med Hypoth. 1991;35:315.","journal-title":"Med Hypoth"},{"key":"618_CR138","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/S0161-6420(01)00626-1","volume":"108","author":"Group A-REDSR","year":"2001","unstructured":"Group A-REDSR. Risk factors associated with age-related nuclear and cortical cataract a case-control study in the Age-Related Eye Disease Study AREDS Report No. 5. Ophthalmology. 2001;108:1400\u20138.","journal-title":"Ophthalmology"},{"key":"618_CR139","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","volume":"101","author":"BL Clarke","year":"2016","unstructured":"Clarke BL, Brown EM, Collins MT, J\u00fcppner H, Lakatos P, Levine MA, Mannstadt MM, Bilezikian JP, Romanischen AF, Thakker RV. Epidemiology and Diagnosis of Hypoparathyroidism. J Clin Endocrinol Metabol. 2016;101:2284\u201399.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR140","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/0301-4738.121141","volume":"62","author":"VB Gupta","year":"2014","unstructured":"Gupta VB, Rajagopala M, Ravishankar B. Etiopathogenesis of cataract: An appraisal. Indian J Ophthalmol. 2014;62:103.","journal-title":"Indian J Ophthalmol"},{"key":"618_CR141","doi-asserted-by":"publisher","first-page":"101152","DOI":"10.1016\/j.preteyeres.2022.101152","volume":"95","author":"PJ Donaldson","year":"2023","unstructured":"Donaldson PJ, Chen Y, Petrova RS, Grey AC, Lim JC. Regulation of lens water content: Effects on the physiological optics of the lens. Progr Retinal Eye Res. 2023;95:101152.","journal-title":"Progr Retinal Eye Res"},{"key":"618_CR142","first-page":"160","volume":"9","author":"W Wojnar","year":"2020","unstructured":"Wojnar W, Zych M, Borymski S, Kaczmarczyk-Sedlak I. Chrysin Reduces Oxidative Stress but Does Not Affect Polyol Pathway in the Lenses of Type 1 Diabetic Rats. Antioxidants (Basel, Switzerland). 2020;9:160.","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"618_CR143","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1167\/iovs.02-0345","volume":"44","author":"D Tang","year":"2003","unstructured":"Tang D, Borchman D, Yappert MC, Vrensen GF, Rasi V. Influence of age, diabetes, and cataract on calcium, lipid-calcium, and protein-calcium relationships in human lenses. Invest Ophthalmol Vis Sci. 2003;44:2059\u201366.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt 3b","key":"618_CR144","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/eye.1999.125","volume":"13","author":"G Duncan","year":"1999","unstructured":"Duncan G, Wormstone IM. Calcium cell signalling and cataract: role of the endoplasmic reticulum. Eye (Lond). 1999;13(Pt 3b):480\u20133.","journal-title":"Eye (Lond)"},{"key":"618_CR145","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1073\/pnas.1404059112","volume":"112","author":"K Liu","year":"2015","unstructured":"Liu K, Lyu L, Chin D, Gao J, Sun X, Shang F, Caceres A, Chang ML, Rowan S, Peng J, et al. Altered ubiquitin causes perturbed calcium homeostasis, hyperactivation of calpain, dysregulated differentiation, and cataract. Proc Natl Acad Sci U S A. 2015;112:1071\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"618_CR146","first-page":"1250","volume":"25","author":"PD Gupta","year":"2004","unstructured":"Gupta PD, Johar K, Vasavada A. Causative and preventive action of calcium in cataracto-genesis. Acta Pharmacol Sin. 2004;25:1250\u20136.","journal-title":"Acta Pharmacol Sin"},{"key":"618_CR147","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13167-023-00314-8","volume":"14","author":"M Kropp","year":"2023","unstructured":"Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo T-TKS, de Clerck E, Polivka J, Potuznik P, Polivka J, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications\u2014risks and mitigation. EPMA J. 2023;14:21\u201342.","journal-title":"EPMA J"},{"key":"618_CR148","doi-asserted-by":"publisher","first-page":"176","DOI":"10.5603\/EP.a2020.0013","volume":"71","author":"MM Stefanowicz-Rutkowska","year":"2020","unstructured":"Stefanowicz-Rutkowska MM, Baranowska-Jurkun A, Matuszewski W, Bandurska-Stankiewicz EM. Thyroid dysfunction in patients with diabetic retinopathy. Endokrynol Pol. 2020;71:176\u201383.","journal-title":"Endokrynol Pol"},{"key":"618_CR149","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabet Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabet Res Clin Pract"},{"key":"618_CR150","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1210\/er.2018-00163","volume":"40","author":"B Biondi","year":"2019","unstructured":"Biondi B, Kahaly GJ, Robertson RP. Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr Rev. 2019;40:789\u2013824.","journal-title":"Endocr Rev"},{"key":"618_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms25137364","volume":"25","author":"G Nicolini","year":"2024","unstructured":"Nicolini G, Casini G, Posarelli C, Amato R, Lulli M, Balzan S, Forini F. Thyroid Hormone Signaling in Retinal Development and Function: Implications for Diabetic Retinopathy and Age-Related Macular Degeneration. Int J Mol Sci. 2024;25:1.","journal-title":"Int J Mol Sci"},{"key":"618_CR152","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2337\/dc09-1784","volume":"33","author":"JK Yang","year":"2010","unstructured":"Yang JK, Liu W, Shi J, Li YB. An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients. Diabet Care. 2010;33:1018\u201320.","journal-title":"Diabet Care"},{"key":"618_CR153","doi-asserted-by":"publisher","first-page":"1288284","DOI":"10.3389\/fendo.2023.1288284","volume":"14","author":"T Fang","year":"2023","unstructured":"Fang T, Deng X, Wang J, Han F, Liu X, Liu Y, Sun B, Chen L. The effect of hypothyroidism on the risk of diabetes and its microvascular complications: a Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1288284.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"618_CR154","first-page":"12212","volume":"5","author":"J Wu","year":"2015","unstructured":"Wu J, Yue S, Geng J, Liu L, Teng W, Liu L, Chen L. Relationship between Diabetic Retinopathy and Subclinical Hypothyroidism: a meta-analysis. Sci Reports. 2015;5:12212.","journal-title":"Sci Reports"},{"key":"618_CR155","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1089\/thy.2014.0190","volume":"24","author":"T Ittermann","year":"2014","unstructured":"Ittermann T, D\u00f6rr M, V\u00f6lzke H, Tost F, Lehmphul I, K\u00f6hrle J, J\u00fcrgens C. High serum thyrotropin levels are associated with retinal arteriolar narrowing in the general population. Thyroid. 2014;24:1473\u20138.","journal-title":"Thyroid"},{"key":"618_CR156","doi-asserted-by":"publisher","first-page":"e3639","DOI":"10.1002\/dmrr.3639","volume":"39","author":"Y Wang","year":"2023","unstructured":"Wang Y, Lu J, Ni J, Wang M, Shen Y, Lu W, Zhu W, Bao Y, Zhou J. Association of thyroid stimulating hormone and time in range with risk of diabetic retinopathy in euthyroid type 2 diabetes. Diabet Metab Res Rev. 2023;39:e3639.","journal-title":"Diabet Metab Res Rev"},{"key":"618_CR157","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.dsx.2020.05.005","volume":"14","author":"N Reddy","year":"2020","unstructured":"Reddy N, Pradeep TVS, Tirupati S, Sarathi V, Kumar D. Thyroid dysfunction and its association with microvascular complications in patients with type 2 diabetes mellitus in south India. Diabet Metabol Synd: Clin Res Rev. 2020;14:615\u20137.","journal-title":"Diabet Metabol Synd: Clin Res Rev"},{"key":"618_CR158","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2147\/DMSO.S455428","volume":"17","author":"M Xiao","year":"2024","unstructured":"Xiao M, Luo G, Zhang Z, Liu Y, Gong R, Ke J. Correlation Between Thyroid-Related Hormones and Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients with Normal Thyroid Function: A Retrospective Study. Diabet Metab Syndr Obes. 2024;17:1481\u201390.","journal-title":"Diabet Metab Syndr Obes"},{"key":"618_CR159","doi-asserted-by":"publisher","first-page":"8161797","DOI":"10.1155\/2020\/8161797","volume":"2020","author":"J Zou","year":"2020","unstructured":"Zou J, Li Z, Tian F, Zhang Y, Xu C, Zhai J, Shi M, Wu G, Zhang Z, Yang C, et al. Association between Normal Thyroid Hormones and Diabetic Retinopathy in Patients with Type 2 Diabetes. Biomed Res Int. 2020;2020:8161797.","journal-title":"Biomed Res Int"},{"key":"618_CR160","doi-asserted-by":"publisher","first-page":"2249017","DOI":"10.1080\/07853890.2023.2249017","volume":"55","author":"X Zhao","year":"2023","unstructured":"Zhao X, Sun J, Xu X, Xin S, Zhang X. The effect of Central and peripheral thyroid resistance indices on diabetic retinopathy: a study of hospitalized euthyroid patients with T2DM in China. Ann Med. 2023;55:2249017.","journal-title":"Ann Med"},{"key":"618_CR161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.19080\/JETR.2018.03.555605","volume":"3","author":"S Sailesh","year":"2018","unstructured":"Sailesh S. The THOR Effect: Thyroid Hormone Offsets Retinopathy. J Endocrinol Thyroid Res. 2018;3:1.","journal-title":"J Endocrinol Thyroid Res"},{"key":"618_CR162","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2337\/diacare.28.4.850","volume":"28","author":"JM Barker","year":"2005","unstructured":"Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, Hoffenberg E, Nelson JC, Gottlieb PA, Rewers M, Eisenbarth GS. Autoantibody \u201csubspecificity\u201d in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabet Care. 2005;28:850\u20135.","journal-title":"Diabet Care"},{"key":"618_CR163","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/pedi.13154","volume":"22","author":"M Wysocka-Mincewicz","year":"2021","unstructured":"Wysocka-Mincewicz M, Baszy\u0144ska-Wilk M, Go\u0142\u0119biewska J, Olechowski A, Byczy\u0144ska A, Hautz W, Szalecki M. The effect of coexisting autoimmune thyroiditis in children with Type 1 diabetes on optical coherence tomography results. Pediatric Diabet. 2021;22:329\u201334.","journal-title":"Pediatric Diabet"},{"key":"618_CR164","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1089\/thy.2024.0257","volume":"34","author":"C Ellervik","year":"2024","unstructured":"Ellervik C, Boulakh L, Teumer A, Marouli E, Ku\u015b A, Buch Hesgaard H, Heegaard S, Blankers L, Sterenborg R, \u00c5svold BO, et al. Thyroid Function, Diabetes, and Common Age-Related Eye Diseases: A Mendelian Randomization Study. Thyroid. 2024;34:1414\u201323.","journal-title":"Thyroid"},{"key":"618_CR165","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12020-015-0643-5","volume":"51","author":"A Rogowicz-Frontczak","year":"2016","unstructured":"Rogowicz-Frontczak A, Pilacinski S, Chwialkowska AT, Wierusz-Wysocka B, Zozuli\u0144ska-Zi\u00f3\u0142kiewicz D. Patients with diabetes type 1 and thyroid autoimmunity have low prevalence of microangiopathic complications. Endocrine. 2016;51:185\u20138.","journal-title":"Endocrine"},{"key":"618_CR166","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12020-018-1582-8","volume":"60","author":"B Falkowski","year":"2018","unstructured":"Falkowski B, Rogowicz-Frontczak A, Grzelka A, Uruska A, Schlaffke J, Araszkiewicz A, Zozulinska-Ziolkiewicz D. Higher free triiodothyronine concentration is associated with lower prevalence of microangiopathic complications and better metabolic control in adult euthyroid people with type 1 diabetes. Endocrine. 2018;60:458\u201365.","journal-title":"Endocrine"},{"key":"618_CR167","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/dme.12530","volume":"31","author":"M Rodacki","year":"2014","unstructured":"Rodacki M, Zajdenverg L, Dantas JR, de Oliveira JE, Luiz RR, Cobas RA, Palma CC, Negrato CA, Gomes MB. Should thyroid-stimulating hormone goals be reviewed in patients with type 1 diabetes mellitus? Results from the Brazilian Type 1 Diabetes Study Group. Diabet Med. 2014;31:1665\u201372.","journal-title":"Diabet Med"},{"key":"618_CR168","first-page":"414","volume":"43","author":"T Schneider","year":"1969","unstructured":"Schneider T, Meyerson L. Thyroid therapy in diabetic retinopathy. S Afr Med J. 1969;43:414\u20137.","journal-title":"S Afr Med J"},{"key":"618_CR169","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pharmthera.2017.02.012","volume":"173","author":"A Mendoza","year":"2017","unstructured":"Mendoza A, Hollenberg AN. New insights into thyroid hormone action. Pharmacol Therapeut. 2017;173:135\u201345.","journal-title":"Pharmacol Therapeut"},{"key":"618_CR170","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/jcp.30563","volume":"237","author":"D Lin","year":"2022","unstructured":"Lin D, Qin R, Guo L. Thyroid stimulating hormone aggravates diabetic retinopathy through the mitochondrial apoptotic pathway. J Cell Physiol. 2022;237:868\u201380.","journal-title":"J Cell Physiol"},{"key":"618_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02892551","volume":"37","author":"S Waber","year":"1981","unstructured":"Waber S, Meister V, Rossi GL, Mordasini RC, Riesen WF. Studies on retinal microangiopathy and coronary macroangiopathy in rats with streptozotocin-induced diabetes. Virchows Archiv B. 1981;37:1\u201310.","journal-title":"Virchows Archiv B"},{"key":"618_CR172","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/00005344-198913040-00002","volume":"13","author":"Y Takiguchi","year":"1989","unstructured":"Takiguchi Y, Satoh N, Hashimoto H, Nakashima M. Reversal effect of thyroxine on altered vascular reactivity in diabetic rats. J Cardiovasc Pharmacol. 1989;13:520\u20134.","journal-title":"J Cardiovasc Pharmacol"},{"key":"618_CR173","first-page":"1","volume":"19","author":"W Wang","year":"2018","unstructured":"Wang W, Lo ACY. Diabetic Retinopathy: Pathophysiology and Treatments. Int J Mol Sci. 2018;19:1.","journal-title":"Int J Mol Sci"},{"key":"618_CR174","first-page":"3908","volume":"83","author":"M Iitaka","year":"1998","unstructured":"Iitaka M, Miura S, Yamanaka K, Kawasaki S, Kitahama S, Kawakami Y, Kakinuma S, Oosuga I, Wada S, Katayama S. Increased Serum Vascular Endothelial Growth Factor Levels and Intrathyroidal Vascular Area in Patients with Graves\u2019 Disease and Hashimoto\u2019s Thyroiditis. J Clin Endocrinol Metabol. 1998;83:3908\u201312.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR175","unstructured":"Ahmed A, Waris A, Naheed A, Anjum A. Diabetic Retinopathy and its Correlation with Thyroid Profile and Anti Thyroid Antibodies. Journal of Dental and Medical Sciences.2017;16:96-98."},{"key":"618_CR176","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1507\/endocrj.K10E-333","volume":"58","author":"EE T\u00fcremen","year":"2011","unstructured":"T\u00fcremen EE, \u00c7etinarslan B, \u015eahin T, Cant\u00fcrk Z, Tarkun \u0130. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J. 2011;58:349\u201354.","journal-title":"Endocr J"},{"key":"618_CR177","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3390\/cells10071703","volume":"10","author":"M Mrugacz","year":"2021","unstructured":"Mrugacz M, Bryl A, Falkowski M, Zorena K. Integrins: An Important Link between Angiogenesis Inflammation and Eye Diseases. Cells. 2021;10:1703.","journal-title":"Cells"},{"key":"618_CR178","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1530\/JME-13-0252","volume":"52","author":"X Liu","year":"2014","unstructured":"Liu X, Zheng N, Shi YN, Yuan J, Li L. Thyroid hormone induced angiogenesis through the integrin \u03b1v\u03b23\/protein kinase D\/histone deacetylase 5 signaling pathway. J Mol Endocrinol. 2014;52:245\u201354.","journal-title":"J Mol Endocrinol"},{"key":"618_CR179","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.exer.2011.11.003","volume":"94","author":"T Yoshida","year":"2012","unstructured":"Yoshida T, Gong J, Xu Z, Wei Y, Duh EJ. Inhibition of pathological retinal angiogenesis by the integrin \u03b1v\u03b23 antagonist tetraiodothyroacetic acid (tetrac). Exp Eye Res. 2012;94:41\u20138.","journal-title":"Exp Eye Res"},{"key":"618_CR180","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1530\/EJE-08-0797","volume":"160","author":"E Maratou","year":"2009","unstructured":"Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, Alevizaki M, Mitrou P, Lambadiari V, Boutati E, Nikzas D, et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol. 2009;160:785\u201390.","journal-title":"Eur J Endocrinol"},{"key":"618_CR181","first-page":"235","volume":"47","author":"T Popescu","year":"2009","unstructured":"Popescu T, Mo\u0163a M. Dyslipidemia and hypertension in patients with type 2 diabetes and retinopathy. Rom J Intern Med. 2009;47:235\u201341.","journal-title":"Rom J Intern Med"},{"key":"618_CR182","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00125-003-1104-x","volume":"46","author":"HC Looker","year":"2003","unstructured":"Looker HC, Fagot-Campagna A, Gunter EW, Pfeiffer CM, Narayan KM, Knowler WC, Hanson RL. Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia. 2003;46:766\u201372.","journal-title":"Diabetologia"},{"key":"618_CR183","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/112067210801800521","volume":"18","author":"G Baskol","year":"2008","unstructured":"Baskol G, Gumus K, Oner A, Arda H, Karakucuk S. The role of advanced oxidation protein products and total thiols in diabetic retinopathy. Eur J Ophthalmol. 2008;18:792\u20138.","journal-title":"Eur J Ophthalmol"},{"key":"618_CR184","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00018-005-5457-9","volume":"63","author":"P Venditti","year":"2006","unstructured":"Venditti P, Di Meo S. Thyroid hormone-induced oxidative stress. Cell Mol Life Sci. 2006;63:414\u201334.","journal-title":"Cell Mol Life Sci"},{"key":"618_CR185","doi-asserted-by":"publisher","first-page":"166892","DOI":"10.1016\/j.bbadis.2023.166892","volume":"1870","author":"F Forini","year":"2024","unstructured":"Forini F, Nicolini G, Amato R, Balzan S, Saba A, Bertolini A, Andreucci E, Marracci S, Melecchi A, Terlizzi D, et al. Local modulation of thyroid hormone signaling in the retina affects the development of diabetic retinopathy. Biochim Biophy Acta (BBA) - Mol Basis Dis. 2024;1870:166892.","journal-title":"Biochim Biophy Acta (BBA) - Mol Basis Dis"},{"key":"618_CR186","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1365-2265.2007.03102.x","volume":"68","author":"A Rodriguez-Perez","year":"2008","unstructured":"Rodriguez-Perez A, Palos-Paz F, Kaptein E, Visser TJ, Dominguez-Gerpe L, Alvarez-Escudero J, Lado-Abeal J. Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock. Clin Endocrinol. 2008;68:821\u20137.","journal-title":"Clin Endocrinol"},{"key":"618_CR187","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1210\/er.2011-0007","volume":"32","author":"A Boelen","year":"2011","unstructured":"Boelen A, Kwakkel J, Fliers E. Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocr Rev. 2011;32:670\u201393.","journal-title":"Endocr Rev"},{"key":"618_CR188","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10557-019-06870-4","volume":"33","author":"C Vale","year":"2019","unstructured":"Vale C, Neves JS, von Hafe M, Borges-Canha M, Leite-Moreira A. The Role of Thyroid Hormones in Heart Failure. Cardiovasc Drugs Ther. 2019;33:179\u201388.","journal-title":"Cardiovasc Drugs Ther"},{"key":"618_CR189","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.64.15.3","volume":"64","author":"R Bapputty","year":"2023","unstructured":"Bapputty R, Sapa H, Masaru M, Gubitosi-Klug RA. Diabetes Modulates Iodothyronine Deiodinase 2 Expression in the Mouse Retina: A Role for Thyroid Hormone in the Pathogenesis of Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2023;64:3.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR190","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2023.26074","volume":"331","author":"M Fleckenstein","year":"2024","unstructured":"Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U. Age-Related Macular Degeneration: A Review. JAMA. 2024;331:147\u201357.","journal-title":"JAMA"},{"key":"618_CR191","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3109\/02713683.2011.647223","volume":"37","author":"S Bromfield","year":"2012","unstructured":"Bromfield S, Keenan J, Jolly P, McGwin G Jr. A suggested association between hypothyroidism and age-related macular degeneration. Curr Eye Res. 2012;37:549\u201352.","journal-title":"Curr Eye Res"},{"key":"618_CR192","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1167\/iovs.16-19735","volume":"57","author":"B Gopinath","year":"2016","unstructured":"Gopinath B, Liew G, Kifley A, Mitchell P. Thyroid Dysfunction and Ten-Year Incidence of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2016;57:5273\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR193","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3390\/jpm12040602","volume":"12","author":"SH Hung","year":"2022","unstructured":"Hung SH, Xirasagar S, Kuang TT, Chang WW, Cheng YF, Kuo NW, Lin HC. Association of Age-Related Macular Degeneration with Prior Hyperthyroidism and Hypothyroidism: A Case-Control Study. J Pers Med. 2022;12:602.","journal-title":"J Pers Med"},{"key":"618_CR194","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/aos.16705","volume":"102","author":"L Boulakh","year":"2024","unstructured":"Boulakh L, Isaksen JL, Poulsen HE, Faber J, Heegaard S, Nygaard B, Kanters JK, Toft PB, Mortens Udholm P, Bek T, et al. Thyroid dysfunction and exudative age-related macular degeneration - A longitudinal nationwide registry-based cohort study. Acta Ophthalmol. 2024;102:813\u201320.","journal-title":"Acta Ophthalmol"},{"key":"618_CR195","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4103\/joco.joco_174_20","volume":"33","author":"M Farvardin","year":"2021","unstructured":"Farvardin M, Mousavi SE, Zare K, Bazdar S, Farvardin Z, Johari M. Thyroid Dysfunction as a Modifiable Risk Factor for Wet Type Age-Related Macular Degeneration: A Case-Control Study. J Curr Ophthalmol. 2021;33:449\u201352.","journal-title":"J Curr Ophthalmol"},{"key":"618_CR196","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12916-015-0329-0","volume":"13","author":"L Chaker","year":"2015","unstructured":"Chaker L, Buitendijk GHS, Dehghan A, Medici M, Hofman A, Vingerling JR, Franco OH, Klaver CCW, Peeters RP. Thyroid function and age-related macular degeneration: a prospective population-based cohort study - the Rotterdam Study. BMC Med. 2015;13:94.","journal-title":"BMC Med"},{"key":"618_CR197","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ajo.2022.01.026","volume":"239","author":"X Li","year":"2022","unstructured":"Li X, Li H, Cheng J, Wang M, Zhong Y, Shi G, Yu AY. Causal Associations of Thyroid Function and Age-Related Macular Degeneration: A Two-Sample Mendelian Randomization Study. Am J Ophthalmol. 2022;239:108\u201314.","journal-title":"Am J Ophthalmol"},{"key":"618_CR198","doi-asserted-by":"crossref","unstructured":"Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology. 2000;107(12):2224-32.","DOI":"10.1016\/S0161-6420(00)00409-7"},{"key":"618_CR199","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/bjophthalmol-2021-319426","volume":"107","author":"LL Shen","year":"2023","unstructured":"Shen LL, Xie Y, Sun M, Ahluwalia A, Park MM, Young BK, Del Priore LV. Associations of systemic health and medication use with the enlargement rate of geographic atrophy in age-related macular degeneration. Br J Ophthalmol. 2023;107:261\u20136.","journal-title":"Br J Ophthalmol"},{"key":"618_CR200","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1159\/000515273","volume":"64","author":"Z Xu","year":"2021","unstructured":"Xu Z, Zhang M, Zhang Q, Xu T, Tao L. Thyroid Disease Is Associated with Higher Age-Related Macular Degeneration Risk: Results from a Meta-Analysis of Epidemiologic Studies. Ophthal Res. 2021;64:696\u2013703.","journal-title":"Ophthal Res"},{"key":"618_CR201","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.ophtha.2006.09.018","volume":"114","author":"IJ Douglas","year":"2007","unstructured":"Douglas IJ, Cook C, Chakravarthy U, Hubbard R, Fletcher AE, Smeeth L. A case-control study of drug risk factors for age-related macular degeneration. Ophthalmology. 2007;114:1164\u20139.","journal-title":"Ophthalmology"},{"key":"618_CR202","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41419-019-2216-7","volume":"11","author":"H Ma","year":"2020","unstructured":"Ma H, Yang F, Ding XQ. Inhibition of thyroid hormone signaling protects retinal pigment epithelium and photoreceptors from cell death in a mouse model of age-related macular degeneration. Cell Death Dis. 2020;11:24.","journal-title":"Cell Death Dis"},{"key":"618_CR203","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41419-022-04691-2","volume":"13","author":"H Ma","year":"2022","unstructured":"Ma H, Yang F, Ding XQ. Deficiency of thyroid hormone receptor protects retinal pigment epithelium and photoreceptors from cell death in a mouse model of age-related macular degeneration. Cell Death Dis. 2022;13:255.","journal-title":"Cell Death Dis"},{"key":"618_CR204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1523\/ENEURO.0058-23.2023","volume":"10","author":"H Ma","year":"2023","unstructured":"Ma H, Yang F, York LR, Li S, Ding XQ. Excessive Thyroid Hormone Signaling Induces Photoreceptor Degeneration in Mice. eNeuro. 2023;10:1.","journal-title":"eNeuro"},{"key":"618_CR205","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1073\/pnas.1317041111","volume":"111","author":"H Ma","year":"2014","unstructured":"Ma H, Thapa A, Morris L, Redmond TM, Baehr W, Ding XQ. Suppressing thyroid hormone signaling preserves cone photoreceptors in mouse models of retinal degeneration. Proc Natl Acad Sci U S A. 2014;111:3602\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"618_CR206","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1096\/fj.201600715R","volume":"30","author":"F Yang","year":"2016","unstructured":"Yang F, Ma H, Belcher J, Butler MR, Redmond TM, Boye SL, Hauswirth WW, Ding XQ. Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration. Faseb j. 2016;30:4313\u201325.","journal-title":"Faseb j"},{"key":"618_CR207","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41572-020-00231-4","volume":"6","author":"PN Baird","year":"2020","unstructured":"Baird PN, Saw SM, Lanca C, Guggenheim JA, Smith Iii EL, Zhou X, Matsui KO, Wu PC, Sankaridurg P, Chia A, et al. Myopia. Nat Rev Dis Primers. 2020;6:99.","journal-title":"Nat Rev Dis Primers"},{"key":"618_CR208","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ophtha.2018.01.033","volume":"125","author":"BS Modjtahedi","year":"2018","unstructured":"Modjtahedi BS, Ferris FL 3rd, Hunter DG, Fong DS. Public Health Burden and Potential Interventions for Myopia. Ophthalmology. 2018;125:628\u201330.","journal-title":"Ophthalmology"},{"key":"618_CR209","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","volume":"62","author":"IG Morgan","year":"2018","unstructured":"Morgan IG, French AN, Ashby RS, Guo X, Ding X, He M, Rose KA. The epidemics of myopia: Aetiology and prevention. Prog Retin Eye Res. 2018;62:134\u201349.","journal-title":"Prog Retin Eye Res"},{"key":"618_CR210","doi-asserted-by":"publisher","first-page":"Mi","DOI":"10.1167\/iovs.18-25983","volume":"60","author":"S Resnikoff","year":"2019","unstructured":"Resnikoff S, Jonas JB, Friedman D, He M, Jong M, Nichols JJ, Ohno-Matsui K, Smith EL III, Wildsoet CF, Taylor HR, et al. Myopia - A 21st Century Public Health Issue. Invest Ophthalmol Vis Sci. 2019;60:Mi\u2013ii.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR211","doi-asserted-by":"publisher","first-page":"100001","DOI":"10.1016\/j.apjo.2023.100001","volume":"13","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang J, Jin A, Tan X, Ohno-Matsui K, Han X, Luo L, Liu Y. Interocular difference in crystalline lens morphology in children and adolescents with unilateral high myopia. Asia Pac J Ophthalmol (Phila). 2024;13:100001.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"618_CR212","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1167\/iovs.18-26247","volume":"60","author":"J Rozema","year":"2019","unstructured":"Rozema J, Dankert S, Iribarren R, Lanca C, Saw SM. Axial Growth and Lens Power Loss at Myopia Onset in Singaporean Children. Invest Ophthalmol Vis Sci. 2019;60:3091\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR213","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/bjo.2005.078295","volume":"90","author":"S Chandrasekaran","year":"2006","unstructured":"Chandrasekaran S, Petsoglou C, Billson FA, Selva D, Ghabrial R. Refractive change in thyroid eye disease (a neglected clinical sign). Br J Ophthalmol. 2006;90:307\u20139.","journal-title":"Br J Ophthalmol"},{"key":"618_CR214","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/eye.2015.242","volume":"30","author":"WS Kim","year":"2016","unstructured":"Kim WS, Chun YS, Cho BY, Lee JK. Biometric and refractive changes after orbital decompression in Korean patients with thyroid-associated orbitopathy. Eye (Lond). 2016;30:400\u20135.","journal-title":"Eye (Lond)"},{"key":"618_CR215","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/medicina45050048","volume":"45","author":"J Jankauskiene","year":"2009","unstructured":"Jankauskiene J, Jakstaite V, Smalinskas V. Changes of vision and refraction in patients with thyroid pathology. Medicina (Kaunas). 2009;45:378\u201381.","journal-title":"Medicina (Kaunas)"},{"key":"618_CR216","doi-asserted-by":"publisher","first-page":"643275","DOI":"10.1155\/2012\/643275","volume":"2012","author":"J Jankauskiene","year":"2012","unstructured":"Jankauskiene J, Jarusaitiene D. Assessment of visual acuity, refraction changes, and proptosis in different ages of patients with thyroid diseases. Int J Endocrinol. 2012;2012:643275.","journal-title":"Int J Endocrinol"},{"key":"618_CR217","doi-asserted-by":"publisher","first-page":"109184","DOI":"10.1016\/j.exer.2022.109184","volume":"222","author":"P Lian","year":"2022","unstructured":"Lian P, Zhao X, Song H, Tanumiharjo S, Chen J, Wang T, Chen S, Lu L. Metabolic characterization of human intraocular fluid in patients with pathological myopia. Exp Eye Res. 2022;222:109184.","journal-title":"Exp Eye Res"},{"key":"618_CR218","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.clinbiochem.2011.03.032","volume":"44","author":"J Shao","year":"2011","unstructured":"Shao J, Xin Y, Li R, Fan Y. Vitreous and serum levels of transthyretin (TTR) in high myopia patients are correlated with ocular pathologies. Clin Biochem. 2011;44:681\u20135.","journal-title":"Clin Biochem"},{"key":"618_CR219","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.cca.2011.07.021","volume":"412","author":"J Shao","year":"2011","unstructured":"Shao J, Xin Y, Yao Y. Correlation of misfolded transthyretin in abnormal vitreous and high myopia related ocular pathologies. Clin Chim Acta. 2011;412:2117\u201321.","journal-title":"Clin Chim Acta"},{"key":"618_CR220","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.preteyeres.2019.100773","volume":"74","author":"C Boote","year":"2020","unstructured":"Boote C, Sigal IA, Grytz R, Hua Y, Nguyen TD, Girard MJA. Scleral structure and biomechanics. Prog Retin Eye Res. 2020;74:100773.","journal-title":"Prog Retin Eye Res"},{"key":"618_CR221","doi-asserted-by":"publisher","first-page":"112472","DOI":"10.1016\/j.biopha.2021.112472","volume":"145","author":"J Yang","year":"2022","unstructured":"Yang J, Ouyang X, Fu H, Hou X, Liu Y, Xie Y, Yu H, Wang G. Advances in biomedical study of the myopia-related signaling pathways and mechanisms. Biomed Pharmacother. 2022;145:112472.","journal-title":"Biomed Pharmacother"},{"key":"618_CR222","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1161\/01.RES.71.4.831","volume":"71","author":"J Yao","year":"1992","unstructured":"Yao J, Eghbali M. Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy. Response of cardiac fibroblasts to thyroid hormone in vitro. Circ Res. 1992;71:831\u20139.","journal-title":"Circ Res"},{"key":"618_CR223","doi-asserted-by":"publisher","first-page":"E3451","DOI":"10.1073\/pnas.1506113113","volume":"113","author":"E Alonso-Merino","year":"2016","unstructured":"Alonso-Merino E, Mart\u00edn Orozco R, Ru\u00edz-Llorente L, Mart\u00ednez-Iglesias OA, Velasco-Mart\u00edn JP, Montero-Pedrazuela A, Fanjul-Rodr\u00edguez L, Contreras-Jurado C, Regadera J, Aranda A. Thyroid hormones inhibit TGF-\u03b2 signaling and attenuate fibrotic responses. Proc Natl Acad Sci U S A. 2016;113:E3451-60.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"618_CR224","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nm.4447","volume":"24","author":"G Yu","year":"2018","unstructured":"Yu G, Tzouvelekis A, Wang R, Herazo-Maya JD, Ibarra GH, Srivastava A, de Castro JPW, DeIuliis G, Ahangari F, Woolard T, et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function. Nat Med. 2018;24:39\u201349.","journal-title":"Nat Med"},{"key":"618_CR225","doi-asserted-by":"publisher","first-page":"8672","DOI":"10.1038\/s41467-024-52827-z","volume":"15","author":"X Pan","year":"2024","unstructured":"Pan X, Wang L, Yang J, Li Y, Xu M, Liang C, Liu L, Li Z, Xia C, Pang J, et al. TR\u03b2 activation confers AT2-to-AT1 cell differentiation and anti-fibrosis during lung repair via KLF2 and CEBPA. Nat Commun. 2024;15:8672.","journal-title":"Nat Commun"},{"key":"618_CR226","first-page":"m4979","volume":"372","author":"BM Burkholder","year":"2021","unstructured":"Burkholder BM, Jabs DA. Uveitis for the non-ophthalmologist. BMJ (Clinical research ed). 2021;372:m4979.","journal-title":"BMJ (Clinical research ed)"},{"key":"618_CR227","doi-asserted-by":"publisher","first-page":"695904","DOI":"10.3389\/fmed.2021.695904","volume":"8","author":"KA Joltikov","year":"2021","unstructured":"Joltikov KA, Lobo-Chan AM. Epidemiology and Risk Factors in Non-infectious Uveitis: A Systematic Review. Front Med (Lausanne). 2021;8:695904.","journal-title":"Front Med (Lausanne)"},{"key":"618_CR228","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bjo.80.4.332","volume":"80","author":"A Rothova","year":"1996","unstructured":"Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332\u20136.","journal-title":"Br J Ophthalmol"},{"key":"618_CR229","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","volume":"88","author":"OM Durrani","year":"2004","unstructured":"Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88:1159\u201362.","journal-title":"Br J Ophthalmol"},{"key":"618_CR230","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.semarthrit.2019.06.004","volume":"49","author":"JT Rosenbaum","year":"2019","unstructured":"Rosenbaum JT, Bodaghi B, Couto C, Zierhut M, Acharya N, Pavesio C, Tay-Kearney ML, Neri P, Douglas K, Pathai S, et al. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review. Semin Arthritis Rheum. 2019;49:438\u201345.","journal-title":"Semin Arthritis Rheum"},{"key":"618_CR231","first-page":"232","volume":"14","author":"J Bordley","year":"1915","unstructured":"Bordley J. Malignant Uveitis Treated with Thyroid Extract. Trans Am Ophthalmol Soc. 1915;14:232\u201349.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"618_CR232","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamaophthalmol.2017.1009","volume":"135","author":"DS Borkar","year":"2017","unstructured":"Borkar DS, Homayounfar G, Tham VM, Ray KJ, Vinoya AC, Uchida A, Acharya NR. Association Between Thyroid Disease and Uveitis: Results From the Pacific Ocular Inflammation Study. JAMA Ophthalmol. 2017;135:594\u20139.","journal-title":"JAMA Ophthalmol"},{"key":"618_CR233","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1080\/09273948.2020.1762899","volume":"29","author":"CJ Lin","year":"2021","unstructured":"Lin CJ, Tien PT, Chang CP, Hsia NY, Yang YC, Lai CT, Bair H, Chen HS, Tsai YY. Relationship between Uveitis and Thyroid Disease: A 13-Year Nationwide Population-based Cohort Study in Taiwan. Ocul Immunol Inflam. 2021;29:1292\u20138.","journal-title":"Ocul Immunol Inflam"},{"key":"618_CR234","first-page":"515","volume":"14","author":"LB Cantor","year":"1982","unstructured":"Cantor LB, Weber JC, Schlaegel TF Jr. Thyroid dysfunction and uveitis. Ann Ophthalmol. 1982;14:515\u20137.","journal-title":"Ann Ophthalmol"},{"key":"618_CR235","first-page":"42","volume":"14","author":"T Mizoguchi","year":"1991","unstructured":"Mizoguchi T, Amemiya T. Uveitis in patients with Graves\u2019 disease. Metabol, Pediatric, Syst Ophthalmol. 1991;14:42\u20133.","journal-title":"Metabol, Pediatric, Syst Ophthalmol."},{"key":"618_CR236","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/archopht.1960.01840010736016","volume":"64","author":"J O\u2019rourke","year":"1960","unstructured":"O\u2019rourke J. Hypometabolism and Depressed Thyroxine Utilization in Association with Uveitis. Arch Ophthalmol. 1960;64:734\u201343.","journal-title":"Arch Ophthalmol"},{"key":"618_CR237","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1089\/thy.2016.0598","volume":"27","author":"A Rosenblatt","year":"2017","unstructured":"Rosenblatt A, Zaitoon H, Habot-Wilner Z. Association Between Non-Infectious Uveitis and Thyroid Dysfunction: A Case Control Study. Thyroid. 2017;27:757\u201361.","journal-title":"Thyroid"},{"key":"618_CR238","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1542\/peds.104.2.314","volume":"104","author":"E Paul","year":"1999","unstructured":"Paul E, Van Why S, Carpenter TO. Hyperthyroidism: a novel feature of the tubulointerstitial nephritis and uveitis syndrome. Pediatrics. 1999;104:314\u20137.","journal-title":"Pediatrics"},{"key":"618_CR239","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s10157-006-0423-x","volume":"10","author":"I Ebihara","year":"2006","unstructured":"Ebihara I, Hirayama K, Usui J, Seki M, Higuchi F, Oteki T, Kobayashi M, Yamagata K. Tubulointerstitial nephritis and uveitis syndrome associated with hyperthyroidism. Clin Exp Nephrol. 2006;10:216\u201321.","journal-title":"Clin Exp Nephrol"},{"key":"618_CR240","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s10157-011-0505-2","volume":"15","author":"K Yasuda","year":"2011","unstructured":"Yasuda K, Sasaki K, Yamato M, Rakugi H, Isaka Y, Hayashi T. Tubulointerstitial nephritis and uveitis syndrome with transient hyperthyroidism in an elderly patient. Clin Exp Nephrol. 2011;15:927\u201332.","journal-title":"Clin Exp Nephrol"},{"key":"618_CR241","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3928\/01913913-20130205-01","volume":"50","author":"I Asproudis","year":"2013","unstructured":"Asproudis I, Zafeiropoulos P, Katsanos A, Skamantzoura E, Sionti I. Tubulointerstitial nephritis and uveitis syndrome with concomitant Hashimoto\u2019s thyroiditis. J Pediatr Ophthalmol Strabismus. 2013;50:e1-3.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"618_CR242","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/pgmj.65.766.587","volume":"65","author":"N Jaggarao","year":"1989","unstructured":"Jaggarao N, Voth D, Jacobsen J. The Vogt-Koyanagi-Harada syndrome: association with hypothyroidism and diabetes mellitus. Post Med J. 1989;65:587\u20138.","journal-title":"Post Med J"},{"key":"618_CR243","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1346-8138.1994.tb01817.x","volume":"21","author":"HI Chi","year":"1994","unstructured":"Chi HI, Furue M, Ishibashi Y. Vogt-Koyanagi-Harada\u2019s syndrome associated with Hashimoto\u2019s thyroiditis. J Dermatol. 1994;21:683\u20136.","journal-title":"J Dermatol"},{"key":"618_CR244","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1076\/ocii.11.4.309.18268","volume":"11","author":"MP Paroli","year":"2003","unstructured":"Paroli MP, Pinca M, Speranza S, Marino M, Pivetti-Pezzi P. Paracentral corneal melting in a patient with Vogt-Koyanagi-Harada\u2019s syndrome, psoriasis, and Hashimoto\u2019s thyroiditis. Ocul Immunol Inflamm. 2003;11:309\u201313.","journal-title":"Ocul Immunol Inflamm"},{"key":"618_CR245","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2169\/internalmedicine.47.0715","volume":"47","author":"H Suzuki","year":"2008","unstructured":"Suzuki H, Isaka M, Suzuki S. Type 1 diabetes mellitus associated with Graves\u2019 disease and Vogt-Koyanagi-Harada syndrome. Intern Med (Tokyo, Japan). 2008;47:1241\u20134.","journal-title":"Intern Med (Tokyo, Japan)"},{"key":"618_CR246","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2340\/00015555-0454","volume":"88","author":"N Kluger","year":"2008","unstructured":"Kluger N, Mura F, Guillot B, Bessis D. Vogt-koyanagi-harada syndrome associated with psoriasis and autoimmune thyroid disease. Acta Dermato-venereologica. 2008;88:397\u20138.","journal-title":"Acta Dermato-venereologica"},{"key":"618_CR247","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3341\/kjo.2009.23.2.112","volume":"23","author":"JH Seo","year":"2009","unstructured":"Seo JH, Yu HG, Chung H. A case of Vogt-Koyanagi-Harada disease in a patient with Graves disease. Korean J Ophthalmol\u202f: KJO. 2009;23:112\u20133.","journal-title":"Korean J Ophthalmol : KJO"},{"key":"618_CR248","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/09273940802596518","volume":"17","author":"Y Futagami","year":"2009","unstructured":"Futagami Y, Sugita S, Fujimaki T, Yokoyama T, Morio T, Mochizuki M. Bilateral anterior granulomatous keratouveitis with sunset glow fundus in a patient with autoimmune polyglandular syndrome. Ocul Immunol Inflamm. 2009;17:88\u201390.","journal-title":"Ocul Immunol Inflamm"},{"key":"618_CR249","first-page":"56","volume":"38","author":"K Nakao","year":"1994","unstructured":"Nakao K, Ohba N, Otsuka S, Okubo A, Yanagita T, Hashimoto N, Arimura H. HTLV-I associated uveitis and hyperthyroidism. Japan J Ophthalmol. 1994;38:56\u201361.","journal-title":"Japan J Ophthalmol"},{"key":"618_CR250","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/bjo.78.3.163","volume":"78","author":"K Yamaguchi","year":"1994","unstructured":"Yamaguchi K, Mochizuki M, Watanabe T, Yoshimura K, Shirao M, Araki S, Miyata N, Mori S, Kiyokawa T, Takatsuki K. Human T lymphotropic virus type 1 uveitis after Graves\u2019 disease. Br J Ophthalmol. 1994;78:163\u20136.","journal-title":"Br J Ophthalmol"},{"key":"618_CR251","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2169\/internalmedicine.33.564","volume":"33","author":"Y Ozawa","year":"1994","unstructured":"Ozawa Y, Migita M, Watanabe T, Okuda I, Takeshita A, Takagi A, Shishiba Y. Development of Graves\u2019 ophthalmopathy and uveitis after radioiodine therapy for Graves\u2019 disease in a patient with HTLV-I associated myelopathy (HAM). Intern Med (Tokyo, Japan). 1994;33:564\u20138.","journal-title":"Intern Med (Tokyo, Japan)"},{"key":"618_CR252","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF00270582","volume":"73","author":"H Kawai","year":"1995","unstructured":"Kawai H, Yokoi K, Akaike M, Kunishige M, Abe M, Tanouchi Y, Mine H, Mimura Y, Saito S. Graves\u2019 disease in HTLV-I carriers. J Mol Med (Berlin, Germany). 1995;73:85\u20138.","journal-title":"J Mol Med (Berlin, Germany)"},{"key":"618_CR253","first-page":"1904","volume":"80","author":"T Mizokami","year":"1995","unstructured":"Mizokami T, Okamura K, Kohno T, Sato K, Ikenoue H, Kuroda T, Inokuchi K, Fujishima M. Human T-lymphotropic virus type I-associated uveitis in patients with Graves\u2019 disease treated with methylmercaptoimidazole. J Clin Endocrinol Metabol. 1995;80:1904\u20137.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR254","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1349-7006.1998.tb03262.x","volume":"89","author":"A Ono","year":"1998","unstructured":"Ono A, Ikeda E, Mochizuki M, Matsuoka M, Yamaguchi K, Sawada T, Yamane S, Tokudome S, Watanabe T. Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves\u2019 disease and disease activities. Japan J Cancer Res\u202f: Gann. 1998;89:608\u201314.","journal-title":"Japan J Cancer Res : Gann"},{"key":"618_CR255","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00000441-200208000-00012","volume":"324","author":"H Sarui","year":"2002","unstructured":"Sarui H, Sano A, Maruyama T, Nakashima K, Takeda N, Yasuda K. Severe graves ophthalmopathy accompanied by HTLV-1-associated uveitis (HAU) and anti-neutrophil cytoplasmic antibody-related vasculitis: a case report and a review of the literature of HAU with Graves disease. Am J Med Sci. 2002;324:109\u201314.","journal-title":"Am J Med Sci"},{"issue":"Suppl 3","key":"618_CR256","first-page":"582","volume":"11","author":"T Watanabe","year":"1997","unstructured":"Watanabe T, Mochizuki M, Yamaguchi K. HTLV-1 uveitis (HU). Leukemia. 1997;11(Suppl 3):582\u20134.","journal-title":"Leukemia"},{"key":"618_CR257","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jfma.2018.03.002","volume":"117","author":"HP Lin","year":"2018","unstructured":"Lin HP, Wu YH, Yu-Fong Chang J, Wang YP, Chen HM, Sun A. Gastric parietal cell and thyroid autoantibodies in patients with Behcet\u2019s disease. J Formos Med Assoc. 2018;117:505\u201311.","journal-title":"J Formos Med Assoc"},{"key":"618_CR258","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1468-3083.2006.01553.x","volume":"20","author":"S Akdeniz","year":"2006","unstructured":"Akdeniz S, Colak S, Tuzcu AK, Bahceci M, Harman M. Baseline and stimulated thyroid functions in Beh\u00e7et\u2019s disease. J Eur Acad Dermatol Venereol. 2006;20:878\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"618_CR259","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.3390\/nu7053813","volume":"7","author":"M-Y Xu","year":"2015","unstructured":"Xu M-Y, Cao B, Yin J, Wang D-F, Chen K-L, Lu Q-B. Vitamin D and Graves\u2019 Disease: A Meta-Analysis Update. Nutrients. 2015;7:3813\u201327.","journal-title":"Nutrients"},{"key":"618_CR260","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/jamaophthalmol.2016.4888","volume":"135","author":"LA Grotting","year":"2017","unstructured":"Grotting LA, Davoudi S, Palenzuela D, Papaliodis GN, Sobrin L. Association of Low Vitamin D Levels With Noninfectious Anterior Uveitis. JAMA Ophthalmol. 2017;135:150\u20133.","journal-title":"JAMA Ophthalmol"},{"key":"618_CR261","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1001\/jamaophthalmol.2017.0776","volume":"135","author":"SJ Garg","year":"2017","unstructured":"Garg SJ. Autoimmune Thyroid Disease and Uveitis. JAMA Ophthalmol. 2017;135:599\u2013600.","journal-title":"JAMA Ophthalmol"},{"key":"618_CR262","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1600-0420.1996.tb00679.x","volume":"74","author":"K Bilgihan","year":"1996","unstructured":"Bilgihan K, Bilgihan A, Diker S, Ataoglu O, Dolapci M, Akata F, Hasanreis\u00f4glu B, Turkozkan N. Effects of hyper- and hypo- thyroidism on oxidative stress of the eye in experimental acute anterior uveitis. Acta Ophthalmol Scand. 1996;74:41\u20133.","journal-title":"Acta Ophthalmol Scand"},{"key":"618_CR263","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS. Graves\u2019 ophthalmopathy. New England J Med. 2010;362:726\u201338.","journal-title":"New England J Med"},{"key":"618_CR264","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/BF03350193","volume":"11","author":"WM Wiersinga","year":"1988","unstructured":"Wiersinga WM, Smit T, van der Gaag R, Koornneef L. Temporal relationship between onset of Graves\u2019 ophthalmopathy and onset of thyroidal Graves\u2019 disease. J Endocrinol Invest. 1988;11:615\u20139.","journal-title":"J Endocrinol Invest"},{"key":"618_CR265","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/bjo.80.12.1042","volume":"80","author":"AJ Otto","year":"1996","unstructured":"Otto AJ, Koornneef L, Mourits MP, Deen-van Leeuwen L. Retrobulbar pressures measured during surgical decompression of the orbit. Br J Ophthalmol. 1996;80:1042\u20135.","journal-title":"Br J Ophthalmol"},{"key":"618_CR266","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","volume":"329","author":"RS Bahn","year":"1993","unstructured":"Bahn RS, Heufelder AE. Pathogenesis of Graves\u2019 ophthalmopathy. New England J Med. 1993;329:1468\u201375.","journal-title":"New England J Med"},{"key":"618_CR267","doi-asserted-by":"publisher","first-page":"615993","DOI":"10.3389\/fendo.2020.615993","volume":"11","author":"L Bartalena","year":"2020","unstructured":"Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML. Epidemiology, Natural History, Risk Factors, and Prevention of Graves\u2019 Orbitopathy. Front Endocrinol (Lausanne). 2020;11:615993.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"618_CR268","doi-asserted-by":"publisher","first-page":"1340415","DOI":"10.3389\/fendo.2024.1340415","volume":"15","author":"GJ H\u00f6tte","year":"2024","unstructured":"H\u00f6tte GJ, Kolijn PM, de Bie M, de Keizer ROB, Medici M, van der Weerd K, van Hagen PM, Paridaens D, Dik WA. Thyroid stimulating immunoglobulin concentration is associated with disease activity and predicts response to treatment with intravenous methylprednisolone in patients with Graves\u2019 orbitopathy. Front Endocrinol (Lausanne). 2024;15:1340415.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"618_CR269","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40618-021-01652-y","volume":"45","author":"M Sari\u0107 Matutinovi\u0107","year":"2022","unstructured":"Sari\u0107 Matutinovi\u0107 M, Diana T, Nedeljkovi\u0107 Beleslin B, \u0106iri\u0107 J, \u017darkovi\u0107 M, Kahaly GJ, Ignjatovi\u0107 S. Clinical value of functional thyrotropin receptor antibodies in Serbian patients with Graves\u2019 orbitopathy. J Endocrinol Invest. 2022;45:189\u201397.","journal-title":"J Endocrinol Invest"},{"key":"618_CR270","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","volume":"52","author":"MN Gerding","year":"2000","unstructured":"Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF. Association of thyrotrophin receptor antibodies with the clinical features of Graves\u2019 ophthalmopathy. Clin Endocrinol. 2000;52:267\u201371.","journal-title":"Clin Endocrinol"},{"key":"618_CR271","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1210\/jc.2009-2470","volume":"95","author":"SD Lytton","year":"2010","unstructured":"Lytton SD, Ponto KA, Kanitz M, Matheis N, Kohn LD, Kahaly GJ. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves\u2019 orbitopathy. J Clin Endocrinol Metabol. 2010;95:2123\u201331.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR272","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s40618-020-01353-y","volume":"44","author":"F Nicol\u00ec","year":"2021","unstructured":"Nicol\u00ec F, Lanzolla G, Mantuano M, Ionni I, Mazzi B, Leo M, Sframeli A, Posarelli C, Maglionico MN, Figus M, et al. Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves\u2019 orbitopathy. J Endocrinol Invest. 2021;44:581\u20135.","journal-title":"J Endocrinol Invest"},{"key":"618_CR273","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1210\/jc.2016-2762","volume":"102","author":"R Fernando","year":"2017","unstructured":"Fernando R, Placzek E, Reese EA, Placzek AT, Schwartz S, Trierweiler A, Niziol LM, Raychaudhuri N, Atkins S, Scanlan TS, Smith TJ. Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy. J Clin Endocrinol Metabol. 2017;102:776\u201385.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR274","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1210\/jc.2005-2813","volume":"91","author":"AK Eckstein","year":"2006","unstructured":"Eckstein AK, Plicht M, Lax H, Neuh\u00e4user M, Mann K, Lederbogen S, Heckmann C, Esser J, Morgenthaler NG. Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metabol. 2006;91:3464\u201370.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR275","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1210\/jc.2011-0307","volume":"96","author":"WM Wiersinga","year":"2011","unstructured":"Wiersinga WM. Autoimmunity in Graves\u2019 ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? J Clin Endocrinol Metabol. 2011;96:2386\u201394.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR276","first-page":"747","volume":"14","author":"HB Burch","year":"1993","unstructured":"Burch HB, Wartofsky L. Graves\u2019 ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev. 1993;14:747\u201393.","journal-title":"Endocr Rev"},{"key":"618_CR277","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1210\/en.2013-1576","volume":"154","author":"S Moshkelgosha","year":"2013","unstructured":"Moshkelgosha S, So PW, Deasy N, Diaz-Cano S, Banga JP. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves\u2019 orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation. Endocrinology. 2013;154:3008\u201315.","journal-title":"Endocrinology"},{"key":"618_CR278","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1210\/en.2011-1846","volume":"153","author":"M Nakahara","year":"2012","unstructured":"Nakahara M, Johnson K, Eckstein A, Taguchi R, Yamada M, Abiru N, Nagayama Y. Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice. Endocrinology. 2012;153:2034\u201342.","journal-title":"Endocrinology"},{"key":"618_CR279","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1089\/thy.2020.0088","volume":"31","author":"M Zhang","year":"2021","unstructured":"Zhang M, Ding X, Wu LP, He MQ, Chen ZY, Shi BY, Wang Y. A Promising Mouse Model of Graves\u2019 Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit. Thyroid. 2021;31:638\u201348.","journal-title":"Thyroid"},{"key":"618_CR280","doi-asserted-by":"publisher","first-page":"101366","DOI":"10.1016\/j.beem.2019.101366","volume":"34","author":"SM Ferrari","year":"2020","unstructured":"Ferrari SM, Fallahi P, Elia G, Ragusa F, Camastra S, Paparo SR, Giusti C, Gonnella D, Ruffilli I, Shoenfeld Y, Antonelli A. Novel therapies for thyroid autoimmune diseases: An update. Best Pract Res Clin Endocrinol Metabol. 2020;34:101366.","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"618_CR281","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0140-6736(93)91475-2","volume":"342","author":"A Feliciello","year":"1993","unstructured":"Feliciello A, Porcellini A, Ciullo I, Bonavolont\u00e0 G, Avvedimento EV, Fenzi G. Expression of thyrotropin-receptor mRNA in healthy and Graves\u2019 disease retro-orbital tissue. Lancet (London, England). 1993;342:337\u20138.","journal-title":"Lancet (London, England)"},{"key":"618_CR282","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1677\/jme.0.0300369","volume":"30","author":"KJ Starkey","year":"2003","unstructured":"Starkey KJ, Janezic A, Jones G, Jordan N, Baker G, Ludgate M. Adipose thyrotrophin receptor expression is elevated in Graves\u2019 and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol. 2003;30:369\u201380.","journal-title":"J Mol Endocrinol"},{"key":"618_CR283","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/bjo.2004.050807","volume":"89","author":"A Boschi","year":"2005","unstructured":"Boschi A, Daumerie C, Spiritus M, Beguin C, Senou M, Yuksel D, Duplicy M, Costagliola S, Ludgate M, Many MC. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy. Br J Ophthalmol. 2005;89:724\u20139.","journal-title":"Br J Ophthalmol"},{"key":"618_CR284","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40618-019-01116-4","volume":"43","author":"YP Hai","year":"2020","unstructured":"Hai YP, Lee ACH, Frommer L, Diana T, Kahaly GJ. Immunohistochemical analysis of human orbital tissue in Graves\u2019 orbitopathy. J Endocrinol Invest. 2020;43:123\u201337.","journal-title":"J Endocrinol Invest"},{"key":"618_CR285","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","volume":"58","author":"IM Wakelkamp","year":"2003","unstructured":"Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF. TSH-R expression and cytokine profile in orbital tissue of active vs inactive Graves\u2019 ophthalmopathy patients. Clin Endocrinol. 2003;58:280\u20137.","journal-title":"Clin Endocrinol"},{"key":"618_CR286","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1210\/er.2018-00066","volume":"40","author":"TJ Smith","year":"2019","unstructured":"Smith TJ, Janssen J. Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy. Endocr Rev. 2019;40:236\u201367.","journal-title":"Endocr Rev"},{"key":"618_CR287","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1080\/02713683.2018.1501075","volume":"43","author":"HY Choi","year":"2018","unstructured":"Choi HY, Jeon H, Yang JW, Ahn JH, Jung JH. Thyroid-Stimulating Hormone Receptor Expression on Primary Cultured Human Extraocular Muscle Myoblasts. Curr Eye Res. 2018;43:1484\u20138.","journal-title":"Curr Eye Res"},{"key":"618_CR288","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1167\/iovs.06-0596","volume":"47","author":"L Zhang","year":"2006","unstructured":"Zhang L, Baker G, Janus D, Paddon CA, Fuhrer D, Ludgate M. Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci. 2006;47:5197\u2013203.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR289","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/JME-11-0006","volume":"46","author":"S Kumar","year":"2011","unstructured":"Kumar S, Nadeem S, Stan MN, Coenen M, Bahn RS. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves\u2019 ophthalmopathy. J Mol Endocrinol. 2011;46:155\u201363.","journal-title":"J Mol Endocrinol"},{"key":"618_CR290","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1089\/105072501753210984","volume":"11","author":"SC Jyonouchi","year":"2001","unstructured":"Jyonouchi SC, Valyasevi RW, Harteneck DA, Dutton CM, Bahn RS. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves\u2019 ophthalmopathy. Thyroid. 2001;11:929\u201334.","journal-title":"Thyroid"},{"key":"618_CR291","doi-asserted-by":"publisher","first-page":"26447","DOI":"10.1074\/jbc.M109.003616","volume":"284","author":"L Zhang","year":"2009","unstructured":"Zhang L, Bowen T, Grennan-Jones F, Paddon C, Giles P, Webber J, Steadman R, Ludgate M. Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. J Biol Chem. 2009;284:26447\u201355.","journal-title":"J Biol Chem"},{"key":"618_CR292","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1167\/iovs.19-27865","volume":"60","author":"CF Woeller","year":"2019","unstructured":"Woeller CF, Roztocil E, Hammond C, Feldon SE. TSHR Signaling Stimulates Proliferation Through PI3K\/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts. Invest Ophthalmol Vis Sci. 2019;60:4336\u201345.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR293","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3390\/cimb43030126","volume":"43","author":"MS Draman","year":"2021","unstructured":"Draman MS, Grennan-Jones F, Taylor P, Muller I, Evans S, Haridas A, Morris DS, Rees DA, Lane C, Dayan C, et al. Expression of Endogenous Putative TSH Binding Protein in Orbit. Curr Issues Mol Biol. 2021;43:1794\u2013804.","journal-title":"Curr Issues Mol Biol"},{"key":"618_CR294","doi-asserted-by":"publisher","first-page":"653627","DOI":"10.3389\/fendo.2021.653627","volume":"12","author":"TJ Smith","year":"2021","unstructured":"Smith TJ. Insulin-Like Growth Factor Pathway and the Thyroid. Front Endocrinol (Lausanne). 2021;12:653627.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"618_CR295","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40618-021-01663-9","volume":"45","author":"EJ Neag","year":"2022","unstructured":"Neag EJ, Smith TJ. 2021 update on thyroid-associated ophthalmopathy. J Endocrinol Invest. 2022;45:235\u201359.","journal-title":"J Endocrinol Invest"},{"key":"618_CR296","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.4049\/jimmunol.170.12.6348","volume":"170","author":"J Pritchard","year":"2003","unstructured":"Pritchard J, Han R, Horst N, Cruikshank WW, Smith TJ. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves\u2019 disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol. 2003;170:6348\u201354.","journal-title":"J Immunol"},{"key":"618_CR297","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","volume":"181","author":"S Tsui","year":"2008","unstructured":"Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A, Gianoukakis AG, Douglas RS, Smith TJ. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease. J Immunol. 2008;181:4397\u2013405.","journal-title":"J Immunol"},{"key":"618_CR298","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1210\/en.2017-00528","volume":"158","author":"CC Krieger","year":"2017","unstructured":"Krieger CC, Perry JD, Morgan SJ, Kahaly GJ, Gershengorn MC. TSH\/IGF-1 Receptor Cross-Talk Rapidly Activates Extracellular Signal-Regulated Kinases in Multiple Cell Types. Endocrinology. 2017;158:3676\u201383.","journal-title":"Endocrinology"},{"key":"618_CR299","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1167\/iovs.65.2.25","volume":"65","author":"M Zhou","year":"2024","unstructured":"Zhou M, Lin B, Wu P, Ke Y, Huang S, Zhang F, Hei X, Mao Z, Li X, Wan P, et al. SOX9 Induces Orbital Fibroblast Activation in Thyroid Eye Disease Via MAPK\/ERK1\/2 Pathway. Invest Ophthalmol Vis Sci. 2024;65:25.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR300","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1210\/jc.2004-0716","volume":"89","author":"TJ Smith","year":"2004","unstructured":"Smith TJ, Hoa N. Immunoglobulins from patients with Graves\u2019 disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. J Clin Endocrinol Metabol. 2004;89:5076\u201380.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR301","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1210\/jc.2015-2932","volume":"101","author":"L Zhang","year":"2016","unstructured":"Zhang L, Ji QH, Ruge F, Lane C, Morris D, Tee AR, Dayan CM, Ludgate M. Reversal of Pathological Features of Graves\u2019 Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs. J Clin Endocrinol Metabol. 2016;101:114\u201322.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR302","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1089\/thy.2015.0254","volume":"25","author":"S Kumar","year":"2015","unstructured":"Kumar S, Coenen M, Iyer S, Bahn RS. Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves\u2019 Ophthalmopathy. Thyroid. 2015;25:1145\u201350.","journal-title":"Thyroid"},{"key":"618_CR303","doi-asserted-by":"publisher","first-page":"8888913","DOI":"10.1155\/2021\/8888913","volume":"2021","author":"YH Wei","year":"2021","unstructured":"Wei YH, Liao SL, Wang CC, Wang SH, Tang WC, Yang CH. Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves\u2019 Ophthalmopathy through the Regulation of FoxO3a Signaling. Med Inflamm. 2021;2021:8888913.","journal-title":"Med Inflamm"},{"key":"618_CR304","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12020-023-03382-y","volume":"82","author":"R Liu","year":"2023","unstructured":"Liu R, Ye Z, Liu Q, Xuan M, Li R, Zhang L, Zhang K, Fang P, Xue Y. MicroRNA-376b is involved in the pathogenesis of thyroid-associated ophthalmopathy by regulating HAS2. Endocrine. 2023;82:87\u201395.","journal-title":"Endocrine"},{"key":"618_CR305","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-1-31","volume":"1","author":"I Aerts","year":"2006","unstructured":"Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, Brisse H, Doz F, Desjardins L. Retinoblastoma. Orphanet J Rare Dis. 2006;1:31.","journal-title":"Orphanet J Rare Dis"},{"key":"618_CR306","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMra1803083","volume":"390","author":"D Cobrinik","year":"2024","unstructured":"Cobrinik D. Retinoblastoma Origins and Destinations. New England J Med. 2024;390:1408\u201319.","journal-title":"New England J Med"},{"key":"618_CR307","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12964-023-01223-z","volume":"21","author":"VV Byroju","year":"2023","unstructured":"Byroju VV, Nadukkandy AS, Cordani M, Kumar LD. Retinoblastoma: present scenario and future challenges. Cell Commun Signal. 2023;21:226.","journal-title":"Cell Commun Signal"},{"key":"618_CR308","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1038\/s41467-021-24781-7","volume":"12","author":"JL Norrie","year":"2021","unstructured":"Norrie JL, Nityanandam A, Lai K, Chen X, Wilson M, Stewart E, Griffiths L, Jin H, Wu G, Orr B, et al. Retinoblastoma from human stem cell-derived retinal organoids. Nat Commun. 2021;12:4535.","journal-title":"Nat Commun"},{"key":"618_CR309","first-page":"79","volume":"5","author":"PL Chen","year":"1995","unstructured":"Chen PL, Riley DJ, Lee WH. The retinoblastoma protein as a fundamental mediator of growth and differentiation signals. Crit Rev Eukaryot Gene Expr. 1995;5:79\u201395.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"618_CR310","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.cell.2009.03.051","volume":"137","author":"XL Xu","year":"2009","unstructured":"Xu XL, Fang Y, Lee TC, Forrest D, Gregory-Evans C, Almeida D, Liu A, Jhanwar SC, Abramson DH, Cobrinik D. Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell. 2009;137:1018\u201331.","journal-title":"Cell"},{"key":"618_CR311","doi-asserted-by":"publisher","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","volume":"1","author":"H Dimaras","year":"2015","unstructured":"Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F, Gallie BL. Retinoblastoma. Nat Rev Dis Primers. 2015;1:15021.","journal-title":"Nat Rev Dis Primers"},{"key":"618_CR312","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1074\/jbc.AC118.006041","volume":"294","author":"Z Li","year":"2019","unstructured":"Li Z, Qi DL, Singh HP, Zou Y, Shen B, Cobrinik D. A novel thyroid hormone receptor isoform, TR\u03b22-46, promotes SKP2 expression and retinoblastoma cell proliferation. J Biol Chem. 2019;294:2961\u20139.","journal-title":"J Biol Chem"},{"key":"618_CR313","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/12013","volume":"1","author":"AC Carrano","year":"1999","unstructured":"Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999;1:193\u20139.","journal-title":"Nat Cell Biol"},{"key":"618_CR314","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1158\/0008-5472.CAN-16-3299","volume":"77","author":"XL Xu","year":"2017","unstructured":"Xu XL, Li Z, Liu A, Fan X, Hu DN, Qi DL, Chitty DW, Jia R, Qui J, Wang JQ, et al. SKP2 Activation by Thyroid Hormone Receptor \u03b22 Bypasses Rb-Dependent Proliferation in Rb-Deficient Cells. Cancer Res. 2017;77:6838\u201350.","journal-title":"Cancer Res"},{"key":"618_CR315","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.tem.2009.03.011","volume":"20","author":"A Aranda","year":"2009","unstructured":"Aranda A, Mart\u00ednez-Iglesias O, Ruiz-Llorente L, Garc\u00eda-Carpizo V, Zambrano A. Thyroid receptor: roles in cancer. Trends Endocrinol Metab. 2009;20:318\u201324.","journal-title":"Trends Endocrinol Metab"},{"key":"618_CR316","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/onc.2010.464","volume":"30","author":"S Garc\u00eda-Silva","year":"2011","unstructured":"Garc\u00eda-Silva S, Mart\u00ednez-Iglesias O, Ruiz-Llorente L, Aranda A. Thyroid hormone receptor \u03b21 domains responsible for the antagonism with the ras oncogene: role of corepressors. Oncogene. 2011;30:854\u201364.","journal-title":"Oncogene"},{"key":"618_CR317","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1210\/en.2010-0475","volume":"151","author":"CJ Guigon","year":"2010","unstructured":"Guigon CJ, Kim DW, Zhu X, Zhao L, Cheng SY. Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression. Endocrinology. 2010;151:5528\u201336.","journal-title":"Endocrinology"},{"key":"618_CR318","first-page":"282","volume":"44","author":"F Leduc","year":"1989","unstructured":"Leduc F, Brauch H, Hajj C, Dobrovic A, Kaye F, Gazdar A, Harbour JW, Pettengill OS, Sorenson GD, van den Berg A, et al. Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers. Am J Hum Genet. 1989;44:282\u20137.","journal-title":"Am J Hum Genet"},{"key":"618_CR319","first-page":"606","volume":"2","author":"DW Kim","year":"2012","unstructured":"Kim DW, Zhao L, Hanover J, Willingham M, Cheng SY. Thyroid hormone receptor \u03b2 suppresses SV40-mediated tumorigenesis via novel nongenomic actions. Am J Cancer Res. 2012;2:606\u201319.","journal-title":"Am J Cancer Res"},{"key":"618_CR320","doi-asserted-by":"publisher","first-page":"9040","DOI":"10.1073\/pnas.94.17.9040","volume":"94","author":"KH Chang","year":"1997","unstructured":"Chang KH, Chen Y, Chen TT, Chou WH, Chen PL, Ma YY, Yang-Feng TL, Leng X, Tsai MJ, O\u2019Malley BW, Lee WH. A thyroid hormone receptor coactivator negatively regulated by the retinoblastoma protein. Proc Natl Acad Sci U S A. 1997;94:9040\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"618_CR321","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","volume":"20","author":"RD Carvajal","year":"2023","unstructured":"Carvajal RD, Sacco JJ, Jager MJ, Eschelman DJ, Olofsson Bagge R, Harbour JW, Chieng ND, Patel SP, Joshua AM, Piperno-Neumann S. Advances in the clinical management of uveal melanoma. Nat Rev Clin Oncol. 2023;20:99\u2013115.","journal-title":"Nat Rev Clin Oncol"},{"key":"618_CR322","doi-asserted-by":"publisher","first-page":"101030","DOI":"10.1016\/j.preteyeres.2021.101030","volume":"89","author":"P Chai","year":"2022","unstructured":"Chai P, Jia R, Li Y, Zhou C, Gu X, Yang L, Shi H, Tian H, Lin H, Yu J, et al. Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma. Prog Retin Eye Res. 2022;89:101030.","journal-title":"Prog Retin Eye Res"},{"key":"618_CR323","doi-asserted-by":"publisher","first-page":"102599","DOI":"10.1016\/j.ctrv.2023.102599","volume":"119","author":"M Wespiser","year":"2023","unstructured":"Wespiser M, Neidhardt E, Negrier S. Uveal melanoma: In the era of new treatments. Cancer Treat Rev. 2023;119:102599.","journal-title":"Cancer Treat Rev"},{"key":"618_CR324","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00008390-199311000-00009","volume":"3","author":"K Sisley","year":"1993","unstructured":"Sisley K, Curtis D, Rennie IG, Rees RC. Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanoma. Melanoma Res. 1993;3:457\u201361.","journal-title":"Melanoma Res"},{"key":"618_CR325","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/CMR.0000000000000329","volume":"27","author":"J Oba","year":"2017","unstructured":"Oba J, Esmaeli B, Ellerhorst JA, Lyons GR, Milton DR, Wang WL, Macedo MP, Lazar AJ, Grimm EA, Chattopadhyay C. Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues: correlation to disease progression. Melanoma Res. 2017;27:126\u201333.","journal-title":"Melanoma Res"},{"key":"618_CR326","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3389\/fendo.2018.00775","volume":"9","author":"O Ashur-Fabian","year":"2018","unstructured":"Ashur-Fabian O, Zloto O, Fabian I, Tsarfaty G, Ellis M, Steinberg DM, Hercbergs A, Davis PJ, Fabian ID. Tetrac Delayed the Onset of Ocular Melanoma in an Orthotopic Mouse Model. Front Endocrinol (Lausanne). 2018;9:775.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"618_CR327","doi-asserted-by":"publisher","first-page":"11038","DOI":"10.18632\/oncotarget.3566","volume":"6","author":"ID Fabian","year":"2015","unstructured":"Fabian ID, Rosner M, Fabian I, Vishnevskia-Dai V, Zloto O, Shinderman Maman E, Cohen K, Ellis M, Lin HY, Hercbergs A, et al. Low thyroid hormone levels improve survival in murine model for ocular melanoma. Oncotarget. 2015;6:11038\u201346.","journal-title":"Oncotarget"},{"key":"618_CR328","doi-asserted-by":"publisher","first-page":"215581","DOI":"10.1016\/j.canlet.2022.215581","volume":"532","author":"C Miro","year":"2022","unstructured":"Miro C, Di Giovanni A, Murolo M, Cicatiello AG, Nappi A, Sagliocchi S, Di Cicco E, Morra F, Celetti A, Pacifico F, et al. Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer. Cancer Lett. 2022;532:215581.","journal-title":"Cancer Lett"},{"key":"618_CR329","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3389\/fphar.2018.01234","volume":"9","author":"L Walcher","year":"2018","unstructured":"Walcher L, Budde C, B\u00f6hm A, Reinach PS, Dhandapani P, Ljubojevic N, Schweiger MW, von der Waydbrink H, Reimers I, K\u00f6hrle J, Mergler S. TRPM8 Activation via 3-Iodothyronamine Blunts VEGF-Induced Transactivation of TRPV1 in Human Uveal Melanoma Cells. Front Pharmacol. 2018;9:1234.","journal-title":"Front Pharmacol"},{"key":"618_CR330","doi-asserted-by":"publisher","first-page":"e2401931","DOI":"10.1002\/advs.202401931","volume":"11","author":"B Li","year":"2024","unstructured":"Li B, Xia C, He W, Liu J, Duan R, Ji Z, Pan X, Zhou Y, Yu G, Wang L. The Thyroid Hormone Analog GC-1 Mitigates Acute Lung Injury by Inhibiting M1 Macrophage Polarization. Adv Sci. 2024;11:e2401931.","journal-title":"Adv Sci"},{"key":"618_CR331","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrendo.2017.172","volume":"14","author":"A Morris","year":"2018","unstructured":"Morris A. Thyroid function: Thyroid hormone therapy resolves pulmonary fibrosis in mice. Nat Rev Endocrinol. 2018;14:64.","journal-title":"Nat Rev Endocrinol"},{"key":"618_CR332","doi-asserted-by":"publisher","first-page":"528686","DOI":"10.3389\/fonc.2020.528686","volume":"10","author":"L Li","year":"2020","unstructured":"Li L, Nie X, Yi M, Qin W, Li F, Wu B, Yuan X. Aerosolized Thyroid Hormone Prevents Radiation Induced Lung Fibrosis. Front Oncol. 2020;10:528686.","journal-title":"Front Oncol"},{"key":"618_CR333","first-page":"81","volume":"46","author":"P Sanders","year":"2011","unstructured":"Sanders P, Young S, Sanders J, Kabelis K, Baker S, Sullivan A, Evans M, Clark J, Wilmot J, Hu X, et al. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. J Mol Endocrinol. 2011;46:81\u201399.","journal-title":"J Mol Endocrinol"},{"key":"618_CR334","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13317-012-0028-1","volume":"4","author":"J Furmaniak","year":"2013","unstructured":"Furmaniak J, Sanders J, Rees Smith B. Blocking type TSH receptor antibodies. Auto-Immun Highlight. 2013;4:11\u201326.","journal-title":"Auto-Immun Highlight"},{"key":"618_CR335","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41586-022-05173-3","volume":"609","author":"J Duan","year":"2022","unstructured":"Duan J, Xu P, Luan X, Ji Y, He X, Song N, Yuan Q, Jin Y, Cheng X, Jiang H, et al. Hormone- and antibody-mediated activation of the thyrotropin receptor. Nature. 2022;609:854\u20139.","journal-title":"Nature"},{"key":"618_CR336","first-page":"1597","volume":"31","author":"M Ryder","year":"2021","unstructured":"Ryder M, Wentworth M, Algeciras-Schimnich A, Morris JC, Garrity J, Sanders J, Young S, Sanders P, Furmaniak J, Rees Smith B. Blocking the Thyrotropin Receptor with K1\u201370 in a Patient with Follicular Thyroid Cancer, Graves\u2019 Disease, and Graves\u2019 Ophthalmopathy. Thyroid Off J Am Thyroid Assoc. 2021;31:1597\u2013602.","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"618_CR337","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/cen.14681","volume":"96","author":"J Furmaniak","year":"2022","unstructured":"Furmaniak J, Sanders J, Sanders P, Li Y, Rees Smith B. TSH receptor specific monoclonal autoantibody K1\u201370(TM) targeting of the TSH receptor in subjects with Graves\u2019 disease and Graves\u2019 orbitopathy-Results from a phase I clinical trial. Clin Endocrinol. 2022;96:878\u201387.","journal-title":"Clin Endocrinol"},{"key":"618_CR338","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1089\/thy.2019.0036","volume":"29","author":"SHS Pearce","year":"2019","unstructured":"Pearce SHS, Dayan C, Wraith DC, Barrell K, Olive N, Jansson L, Walker-Smith T, Carnegie C, Martin KF, Boelaert K, et al. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves\u2019 Hyperthyroidism: A Phase I Study. Thyroid. 2019;29:1003\u201311.","journal-title":"Thyroid"},{"key":"618_CR339","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1210\/jc.2013-1149","volume":"98","author":"AF Turcu","year":"2013","unstructured":"Turcu AF, Kumar S, Neumann S, Coenen M, Iyer S, Chiriboga P, Gershengorn MC, Bahn RS. A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy. J Clin Endocrinol Metabol. 2013;98:2153\u20139.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR340","doi-asserted-by":"publisher","first-page":"E781","DOI":"10.1210\/jc.2011-2931","volume":"97","author":"CJ van Zeijl","year":"2012","unstructured":"van Zeijl CJ, van Koppen CJ, Surovtseva OV, de Gooyer ME, Plate R, Conti P, Karstens WJ, Timmers M, Saeed P, Wiersinga WM, et al. Complete inhibition of rhTSH-, Graves\u2019 disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist. J Clin Endocrinol Metabol. 2012;97:E781-5.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR341","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1167\/iovs.14-14002","volume":"55","author":"Y Wang","year":"2014","unstructured":"Wang Y, Smith TJ. Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci. 2014;55:1735\u201348.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR342","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1210\/jc.2016-1315","volume":"101","author":"CC Krieger","year":"2016","unstructured":"Krieger CC, Place RF, Bevilacqua C, Marcus-Samuels B, Abel BS, Skarulis MC, Kahaly GJ, Neumann S, Gershengorn MC. TSH\/IGF-1 Receptor Cross Talk in Graves\u2019 Ophthalmopathy Pathogenesis. J Clin Endocrinol Metabol. 2016;101:2340\u20137.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR343","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1210\/en.2019-00055","volume":"160","author":"CC Krieger","year":"2019","unstructured":"Krieger CC, Boutin A, Jang D, Morgan SJ, Banga JP, Kahaly GJ, Klubo-Gwiezdzinska J, Neumann S, Gershengorn MC. Arrestin-\u03b2-1 Physically Scaffolds TSH and IGF1 Receptors to Enable Crosstalk. Endocrinology. 2019;160:1468\u201379.","journal-title":"Endocrinology"},{"key":"618_CR344","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1089\/thy.2018.0089","volume":"28","author":"B Marcus-Samuels","year":"2018","unstructured":"Marcus-Samuels B, Krieger CC, Boutin A, Kahaly GJ, Neumann S, Gershengorn MC. Evidence That Graves\u2019 Ophthalmopathy Immunoglobulins Do Not Directly Activate IGF-1 Receptors. Thyroid. 2018;28:650\u20135.","journal-title":"Thyroid"},{"key":"618_CR345","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","volume":"376","author":"TJ Smith","year":"2017","unstructured":"Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, et al. Teprotumumab for Thyroid-Associated Ophthalmopathy. New England J Med. 2017;376:1748\u201361.","journal-title":"New England J Med"},{"key":"618_CR346","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1910434","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marin\u00f2 M, et al. Teprotumumab for the Treatment of Active Thyroid Eye Disease. New England J Med. 2020;382:341\u201352.","journal-title":"New England J Med"},{"key":"618_CR347","doi-asserted-by":"publisher","first-page":"1488220","DOI":"10.3389\/fimmu.2024.1488220","volume":"15","author":"M Luffy","year":"2024","unstructured":"Luffy M, Ganz AL, Wagner S, Wolf J, Ropertz J, Zeidan R, Kent JD, Douglas RS, Kahaly GJ. Linsitinib inhibits proliferation and induces apoptosis of both IGF-1R and TSH-R expressing cells. Front Immunol. 2024;15:1488220.","journal-title":"Front Immunol"},{"key":"618_CR348","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1021\/acs.jmedchem.4c01525","volume":"67","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Tan Y, Zhang Z, Cheng X, Duan J, Li Y. Targeting Thyroid-Stimulating Hormone Receptor: A Perspective on Small-Molecule Modulators and Their Therapeutic Potential. J Med Chem. 2024;67:16018\u201334.","journal-title":"J Med Chem"},{"key":"618_CR349","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jhep.2024.08.008","volume":"82","author":"YH Zhang","year":"2025","unstructured":"Zhang YH, Xie R, Dai CS, Gao HW, Zhou G, Qi TT, Wang WY, Wang H, Cui YM. Thyroid hormone receptor-beta agonist HSK31679 alleviates MASLD by modulating gut microbial sphingolipids. J Hepatol. 2025;82:189\u2013202.","journal-title":"J Hepatol"},{"key":"618_CR350","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/EJE-14-0135","volume":"171","author":"P Laurberg","year":"2014","unstructured":"Laurberg P, Andersen SL. Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk? Eur J Endocrinol. 2014;171:R13-20.","journal-title":"Eur J Endocrinol"},{"key":"618_CR351","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1089\/thy.2015.0058","volume":"25","author":"K Renko","year":"2015","unstructured":"Renko K, Sch\u00e4che S, Hoefig CS, Welsink T, Schwiebert C, Braun D, Becker NP, K\u00f6hrle J, Schomburg L. An Improved Nonradioactive Screening Method Identifies Genistein and Xanthohumol as Potent Inhibitors of Iodothyronine Deiodinases. Thyroid. 2015;25:962\u20138.","journal-title":"Thyroid"},{"key":"618_CR352","doi-asserted-by":"publisher","first-page":"106685","DOI":"10.1016\/j.phrs.2023.106685","volume":"189","author":"S Sagliocchi","year":"2023","unstructured":"Sagliocchi S, Murolo M, Cicatiello AG, Miro C, Nappi A, Di Cicco E, Torabinejad S, La Civita E, Romano V, Terracciano D, et al. Repositioning of Cefuroxime as novel selective inhibitor of the thyroid hormone activating enzyme type 2 deiodinase. Pharmacol Res. 2023;189:106685.","journal-title":"Pharmacol Res"},{"key":"618_CR353","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1038\/s41388-021-02020-z","volume":"40","author":"D Moskovich","year":"2021","unstructured":"Moskovich D, Finkelshtein Y, Alfandari A, Rosemarin A, Lifschytz T, Weisz A, Mondal S, Ungati H, Katzav A, Kidron D, et al. Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. Oncogene. 2021;40:6248\u201357.","journal-title":"Oncogene"},{"key":"618_CR354","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms232213714","volume":"23","author":"GS H\u00f6nes","year":"2022","unstructured":"H\u00f6nes GS, Sivakumar RG, Hoppe C, K\u00f6nig J, F\u00fchrer D, Moeller LC. Cell-Specific Transport and Thyroid Hormone Receptor Isoform Selectivity Account for Hepatocyte-Targeted Thyromimetic Action of MGL-3196. Int J Mol Sci. 2022;23:1.","journal-title":"Int J Mol Sci"},{"key":"618_CR355","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1021\/acs.bioconjchem.9b00742","volume":"30","author":"M Rajabi","year":"2019","unstructured":"Rajabi M, Godugu K, Sudha T, Bharali DJ, Mousa SA. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin \u03b1(v)\u03b2(3) Antagonist with Potent Anticancer Activities in Glioblastoma Multiforme. Bioconjug Chem. 2019;30:3087\u201397.","journal-title":"Bioconjug Chem"},{"key":"618_CR356","doi-asserted-by":"publisher","first-page":"e1136","DOI":"10.1210\/clinem\/dgab750","volume":"107","author":"FS van Geest","year":"2022","unstructured":"van Geest FS, Groeneweg S, van den Akker ELT, Bacos I, Barca D, van den Berg SAA, Bertini E, Brunner D, Brunetti-Pierri N, Cappa M, et al. Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort Study. J Clin Endocrinol Metabol. 2022;107:e1136-47.","journal-title":"J Clin Endocrinol Metabol"},{"key":"618_CR357","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3389\/fendo.2019.00787","volume":"10","author":"J K\u00f6hrle","year":"2019","unstructured":"K\u00f6hrle J, Lehmphul I, Pietzner M, Renko K, Rijntjes E, Richards K, Anselmo J, Danielsen M, Jonklaas J. 3,5-T2-A Janus-Faced Thyroid Hormone Metabolite Exerts Both Canonical T3-Mimetic Endocrine and Intracrine Hepatic Action. Front Endocrinol. 2019;10:787.","journal-title":"Front Endocrinol"},{"key":"618_CR358","doi-asserted-by":"publisher","first-page":"11596","DOI":"10.3390\/ijms241411569","volume":"24","author":"B Polini","year":"2023","unstructured":"Polini B, Ricardi C, Bertolini A, Carnicelli V, Rutigliano G, Saponaro F, Zucchi R, Chiellini G. T1AM\/TAAR1 System Reduces Inflammatory Response and \u03b2-Amyloid Toxicity in Human Microglial HMC3 Cell Line. Int J Mol Sci. 2023;24:11596.","journal-title":"Int J Mol Sci"},{"key":"618_CR359","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.3390\/ijms20164054","volume":"20","author":"M Rogowski","year":"2019","unstructured":"Rogowski M, Bellusci L, Sabatini M, Rapposelli S, Rahman SM, Chiellini G, Assadi-Porter FM. Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway. Int J Mol Sci. 2019;20:4054.","journal-title":"Int J Mol Sci"},{"key":"618_CR360","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1172\/JCI107925","volume":"55","author":"DL Geffner","year":"1975","unstructured":"Geffner DL, Azukizawa M, Hershman JM. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. J Clin Invest. 1975;55:224\u20139.","journal-title":"J Clin Invest"},{"key":"618_CR361","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1172\/JCI107924","volume":"55","author":"M Saberi","year":"1975","unstructured":"Saberi M, Sterling FH, Utiger RD. Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. J Clin Invest. 1975;55:218\u201323.","journal-title":"J Clin Invest"},{"key":"618_CR362","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1210\/mend.14.11.0558","volume":"14","author":"B Gereben","year":"2000","unstructured":"Gereben B, Goncalves C, Harney JW, Larsen PR, Bianco AC. Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. Mol Endocrinol. 2000;14:1697\u2013708.","journal-title":"Mol Endocrinol"},{"key":"618_CR363","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1172\/JCI4672","volume":"102","author":"J Steinsapir","year":"1998","unstructured":"Steinsapir J, Harney J, Larsen PR. Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes. J Clin Invest. 1998;102:1895\u20139.","journal-title":"J Clin Invest"},{"key":"618_CR364","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1056\/NEJM200007203430305","volume":"343","author":"SA Huang","year":"2000","unstructured":"Huang SA, Tu HM, Harney JW, Venihaki M, Butte AJ, Kozakewich HP, Fishman SJ, Larsen PR. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. New England J Med. 2000;343:185\u20139.","journal-title":"New England J Med"},{"key":"618_CR365","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/en.2004-1392","volume":"146","author":"AM Zavacki","year":"2005","unstructured":"Zavacki AM, Ying H, Christoffolete MA, Aerts G, So E, Harney JW, Cheng SY, Larsen PR, Bianco AC. Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse. Endocrinology. 2005;146:1568\u201375.","journal-title":"Endocrinology"},{"key":"618_CR366","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/thy.2018.0349","volume":"29","author":"P Marcinkowski","year":"2019","unstructured":"Marcinkowski P, Hoyer I, Specker E, Furkert J, Rutz C, Neuenschwander M, Sobottka S, Sun H, Nazare M, Berchner-Pfannschmidt U, et al. A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves\u2019 Orbitopathy. Thyroid. 2019;29:111\u201323.","journal-title":"Thyroid"},{"key":"618_CR367","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/thy.2018.0326","volume":"29","author":"J Fa\u00dfbender","year":"2019","unstructured":"Fa\u00dfbender J, Holthoff HP, Li Z, Ungerer M. Therapeutic Effects of Short Cyclic and Combined Epitope Peptides in a Long-Term Model of Graves\u2019 Disease and Orbitopathy. Thyroid. 2019;29:258\u201367.","journal-title":"Thyroid"},{"key":"618_CR368","doi-asserted-by":"publisher","first-page":"9841","DOI":"10.1074\/jbc.C600014200","volume":"281","author":"H J\u00e4schke","year":"2006","unstructured":"J\u00e4schke H, Neumann S, Moore S, Thomas CJ, Colson AO, Costanzi S, Kleinau G, Jiang JK, Paschke R, Raaka BM, et al. A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone\/chorionic gonadotropin receptor (LHCGR). J Biol Chem. 2006;281:9841\u20134.","journal-title":"J Biol Chem"},{"key":"618_CR369","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fendo.2016.00105","volume":"7","author":"S Neumann","year":"2016","unstructured":"Neumann S, Padia U, Cullen MJ, Eliseeva E, Nir EA, Place RF, Morgan SJ, Gershengorn MC. An Enantiomer of an Oral Small-Molecule TSH Receptor Agonist Exhibits Improved Pharmacologic Properties. Front Endocrinol (Lausanne). 2016;7:105.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"618_CR370","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/thy.2014.0119","volume":"25","author":"R Latif","year":"2015","unstructured":"Latif R, Ali MR, Ma R, David M, Morshed SA, Ohlmeyer M, Felsenfeld DP, Lau Z, Mezei M, Davies TF. New small molecule agonists to the thyrotropin receptor. Thyroid. 2015;25:51\u201362.","journal-title":"Thyroid"},{"key":"618_CR371","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1134\/S1607672922020016","volume":"503","author":"AA Bakhtyukov","year":"2022","unstructured":"Bakhtyukov AA, Derkach KV, Fokina EA, Sorokoumov VN, Zakharova IO, Bayunova LV, Shpakov AO. Development of Low-Molecular-Weight Allosteric Agonist of Thyroid-Stimulating Hormone Receptor with Thyroidogenic Activity. Dokl Biochem Biophys. 2022;503:67\u201370.","journal-title":"Dokl Biochem Biophys"},{"key":"618_CR372","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1124\/jpet.117.244095","volume":"364","author":"S Neumann","year":"2018","unstructured":"Neumann S, Eliseeva E, Boutin A, Barnaeva E, Ferrer M, Southall N, Kim D, Hu X, Morgan SJ, Marugan JJ, Gershengorn MC. Discovery of a Positive Allosteric Modulator of the Thyrotropin Receptor: Potentiation of Thyrotropin-Mediated Preosteoblast Differentiation In Vitro. J Pharmacol Exp Ther. 2018;364:38\u201345.","journal-title":"J Pharmacol Exp Ther"},{"key":"618_CR373","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fendo.2020.00372","volume":"11","author":"R Latif","year":"2020","unstructured":"Latif R, Morshed SA, Ma R, Tokat B, Mezei M, Davies TF. A Gq Biased Small Molecule Active at the TSH Receptor. Front Endocrinol (Lausanne). 2020;11:372.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"618_CR374","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/thy.2020.0071","volume":"30","author":"R Zucchi","year":"2020","unstructured":"Zucchi R. Thyroid Hormone Analogues: An Update. Thyroid. 2020;30:1099\u2013105.","journal-title":"Thyroid"},{"key":"618_CR375","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nm.4447","volume":"24","author":"G Yu","year":"2018","unstructured":"Yu G, Tzouvelekis A, Wang R, Herazo-Maya JD, Ibarra GH, Srivastava A, de Castro JPW, DeIuliis G, Ahangari F, Woolard T, et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function. Nat Med. 2018;24:39\u201349.","journal-title":"Nat Med"},{"key":"618_CR376","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","volume":"394","author":"SA Harrison","year":"2019","unstructured":"Harrison SA, Bashir MR, Guy CD, Zhou R, Moylan CA, Frias JP, Alkhouri N, Bansal MB, Baum S, Neuschwander-Tetri BA, et al. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet (London, England). 2019;394:2012\u201324.","journal-title":"Lancet (London, England)"},{"key":"618_CR377","doi-asserted-by":"publisher","first-page":"e12808","DOI":"10.1111\/cpr.12808","volume":"53","author":"A Perra","year":"2020","unstructured":"Perra A, Kowalik MA, Cabras L, Runfola M, Sestito S, Migliore C, Giordano S, Chiellini G, Rapposelli S, Columbano A. Potential role of two novel agonists of thyroid hormone receptor-\u03b2 on liver regeneration. Cell Prolif. 2020;53:e12808.","journal-title":"Cell Prolif"},{"key":"618_CR378","doi-asserted-by":"publisher","first-page":"14840","DOI":"10.1021\/acs.jmedchem.4c01029","volume":"67","author":"K Vandyck","year":"2024","unstructured":"Vandyck K, McGowan DC, Luong XG, Stevens SK, Jekle A, Gupta K, Misner DL, Chanda S, Serebryany V, Welch M, et al. Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-\u03b2) Agonist for the Treatment of MASH. J Med Chem. 2024;67:14840\u201351.","journal-title":"J Med Chem"},{"key":"618_CR379","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/jgh.16874","volume":"40","author":"D Ezhilarasan","year":"2025","unstructured":"Ezhilarasan D. Thyromimetics and MASLD: Unveiling the Novel Molecules Beyond Resmetirom. J Gastroenterol Hepatol. 2025;40:367\u201378.","journal-title":"J Gastroenterol Hepatol"},{"key":"618_CR380","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1507\/endocrj.EJ18-0380","volume":"66","author":"A Yoshihara","year":"2019","unstructured":"Yoshihara A, Luo Y, Ishido Y, Usukura K, Oda K, Sue M, Kawashima A, Hiroi N, Suzuki K. Inhibitory effects of methimazole and propylthiouracil on iodotyrosine deiodinase 1 in thyrocytes. Endocr J. 2019;66:349\u201357.","journal-title":"Endocr J"},{"key":"618_CR381","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0004563220969150","volume":"58","author":"DJ Halsall","year":"2021","unstructured":"Halsall DJ, Oddy S. Clinical and laboratory aspects of 3,3\u2019,5\u2019-triiodothyronine (reverse T3). Ann Clin Biochem. 2021;58:29\u201337.","journal-title":"Ann Clin Biochem"},{"key":"618_CR382","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/nu14153044","volume":"14","author":"A Bouazza","year":"2022","unstructured":"Bouazza A, Favier R, Fontaine E, Leverve X, Koceir EA. Potential Applications of Thyroid Hormone Derivatives in Obesity and Type 2 Diabetes: Focus on 3,5-Diiodothyronine (3,5\u2013T2) in Psammomys obesus (Fat Sand Rat) Model. Nutrients. 2022;14:3044.","journal-title":"Nutrients"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-025-00618-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-025-00618-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-025-00618-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:18:19Z","timestamp":1751437099000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-025-00618-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":382,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1186\/s40659-025-00618-1","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}